Cross Reference Logo
Citations to this article as recorded by CrossRef and RSC Journals (441 citations).

Assembly of ruthenium complexes on double stranded DNA using mismatch binding ligands
Lu Ni, Takeshi Yamada and Kazuhiko Nakatani
Chem. Commun., 2020, 56, 5227
DOI: 10.1039/D0CC01863E

Reactivity of an antimetastatic organometallic ruthenium compound with metallothionein-2: relevance to the mechanism of action
Angela Casini, Andrei Karotki, Chiara Gabbiani, Francesco Rugi, Milan Vašák, Luigi Messori and Paul J. Dyson
Metallomics, 2009, 1, 434
DOI: 10.1039/b909185h

Tuning the hydrophobicity of ruthenium(ii)–arene (RAPTA) drugs to modify uptake, biomolecular interactions and efficacy
Claudine Scolaro, Adrian B. Chaplin, Christian G. Hartinger, Alberta Bergamo, Moreno Cocchietto, Bernhard K. Keppler, Gianni Sava and Paul J. Dyson
Dalton Trans., 2007, 5065
DOI: 10.1039/b705449a

Anti-tumour active gold(i), palladium(ii) and ruthenium(ii) complexes with thio- and selenoureato ligands: a comparative study
Anja Molter, Stefanie Kathrein, Brigitte Kircher and Fabian Mohr
Dalton Trans., 2018, 47, 5055
DOI: 10.1039/C7DT04180B

Cytotoxic (cis,cis-1,3,5-triaminocyclohexane)ruthenium(ii)-diphosphine complexes; evidence for covalent binding and intercalation with DNA
Dan E. Wise, Aimee J. Gamble, Sham W. Arkawazi, Paul H. Walton, M. Carmen Galan, Michael P. O'Hagan, Karen G. Hogg, Joanne L. Marrison, Peter J. O'Toole, Hazel A. Sparkes, Jason M. Lynam and Paul G. Pringle
Dalton Trans., 2020, 49, 15219
DOI: 10.1039/D0DT02612C

Anticancer half-sandwich Ir(iii) complex and its interaction with various biomolecules and their mixtures – a case study with ascorbic acid
Lukáš Masaryk, Jakub Orvoš, Karolina Słoczyńska, Radovan Herchel, Ján Moncol, David Milde, Petr Halaš, Radka Křikavová, Paulina Koczurkiewicz-Adamczyk, Elżbieta Pękala, Róbert Fischer, Ivan Šalitroš, Ivan Nemec and Pavel Štarha
Inorg. Chem. Front., 2022, 9, 3758
DOI: 10.1039/D2QI00535B

Synthesis, characterization, crystal structure, cytotoxicity, apoptosis and cell cycle arrest of ruthenium(ii) complex [Ru(bpy)2(adpa)](PF6)2 (bpy = 2,2′-bipyridine, adpa = 4-(4-aminophenyl)diazenyl-N-(pyridin-2-ylmethylene)aniline)
Yan Zhang, Peng-Chao Hu, Ping Cai, Fang Yang and Gong-Zhen Cheng
RSC Adv., 2015, 5, 11591
DOI: 10.1039/C4RA12715C

A DFT study on the mechanism of a novel, regioselective, intramolecular N–π rearrangement of cis and trans-η1-N-Cp*Rh-hydroxytamoxifen complexes to their η6 derivatives; potential breast cancer pharmaceuticals, and fluorescent probes
Irena Efremenko, Siden Top, Jan M. L. Martin and Richard H. Fish
Dalton Trans., 2009, 4334
DOI: 10.1039/b819474b

Tetranuclear Ru2Cu2 and Ru2Ni2 complexes with nanomolar anticancer activity
Andrés Alguacil, Franco Scalambra, Pablo Lorenzo-Luis, Adrián Puerta, Aday González-Bakker, Zenaida Mendoza, José M. Padrón and Antonio Romerosa
Dalton Trans., 2023, 52, 9541
DOI: 10.1039/D3DT01284K

Maleimide-functionalised organoruthenium anticancer agents and their binding to thiol-containing biomolecules
Muhammad Hanif, Alexey A. Nazarov, Anton Legin, Michael Groessl, Vladimir B. Arion, Michael A. Jakupec, Yury O. Tsybin, Paul J. Dyson, Bernhard K. Keppler and Christian G. Hartinger
Chem. Commun., 2012, 48, 1475
DOI: 10.1039/C1CC14713G

Studies on the DNA binding and anticancer activity of Ru(ii) polypyridyl complexes by using a (2-(4-(diethoxymethyl)-1H-imidazo[4,5-f][1,10] phenanthroline)) intercalative ligand
Ravi Kumar Vuradi, Kamakshi Dandu, Praveen Kumar Yata, Vinoda Rani M., Rajender Reddy Mallepally, Nagamani Chintakuntla, Ravi Ch, Suman S Thakur, Ch. Mohan Rao and Satyanarayana S.
New J. Chem., 2018, 42, 846
DOI: 10.1039/C7NJ03819D

Exploration of the medical periodic table: towards new targets
Nicolas P. E. Barry and Peter J. Sadler
Chem. Commun., 2013, 49, 5106
DOI: 10.1039/c3cc41143e

Metal-based antitumour drugs in the post genomic era
Paul J. Dyson and Gianni Sava
Dalton Trans., 2006, 1929
DOI: 10.1039/b601840h

Ru(ii)–arene azole complexes as anti-amyloid-β agents
Ryan M. Hacker, Daniela M. Grimard, Katie A. Morgan, Eaman Saleh, Morgan M. Wrublik, Cade J. Meiss, Caitlyn C. Kant, Marjorie A. Jones, William W. Brennessel and Michael I. Webb
Dalton Trans., 2024, 53, 18845
DOI: 10.1039/D4DT01740D

Neutral and ionic platinum compounds containing a cyclometallated chiral primary amine: synthesis, antitumor activity, DNA interaction and topoisomerase I–cathepsin B inhibition
Joan Albert, Ramon Bosque, Margarita Crespo, Jaume Granell, Concepción López, Raquel Martín, Asensio González, Anusha Jayaraman, Josefina Quirante, Carme Calvis, Josefa Badía, Laura Baldomà, Mercè Font-Bardia, Marta Cascante and Ramon Messeguer
Dalton Trans., 2015, 44, 13602
DOI: 10.1039/C5DT01713K

Mechanism of protonation induced changes in Raman spectra of a trisheteroleptic ruthenium complex revealed by DFT calculations
Maria Wächtler, Maximilian Bräutigam, Jürgen Popp and Benjamin Dietzek
RSC Adv., 2013, 3, 5597
DOI: 10.1039/c3ra00157a

The use of X-ray absorption and synchrotron based micro-X-ray fluorescence spectroscopy to investigate anti-cancer metal compounds in vivo and in vitro
Alfred A. Hummer and Annette Rompel
Metallomics, 2013, 5, 597
DOI: 10.1039/c3mt20261e

Synthesis and anticancer activity of carbosilane metallodendrimers based on arene ruthenium(ii) complexes
Marta Maroto-Díaz, Benelita T. Elie, Pilar Gómez-Sal, Jorge Pérez-Serrano, Rafael Gómez, María Contel and F. Javier de la Mata
Dalton Trans., 2016, 45, 7049
DOI: 10.1039/C6DT00465B

Complexation with organometallic ruthenium pharmacophores enhances the ability of 4-anilinoquinazolines inducing apoptosis
Wei Zheng, Qun Luo, Yu Lin, Yao Zhao, Xiuli Wang, Zhifeng Du, Xiang Hao, Yang Yu, Shuang Lü, Liyun Ji, Xianchan Li, Ling Yang and Fuyi Wang
Chem. Commun., 2013, 49, 10224
DOI: 10.1039/c3cc43000f

Antitumor activity of new hydridotris(pyrazolyl)borate ruthenium(ii) complexes containing the phosphanes PTA and 1-CH3–PTA
Almudena García-Fernández, Josefina Díez, Ángel Manteca, Jesús Sánchez, Rósula García-Navas, Beatriz G. Sierra, Faustino Mollinedo, M. Pilar Gamasa and Elena Lastra
Dalton Trans., 2010, 39, 10186
DOI: 10.1039/c0dt00206b

A new 3D four-fold interpenetrated dia-like polymer: gas sorption and computational analyses
Jian Wu, Jian-Qiang Liu, Zhen-Bin Jia, Qing-Lin Li, Kai-Bang Li, Hao Li, Carole Daiguebonne, Guillaume Calvez and Olivier Guillou
CrystEngComm, 2014, 16, 10410
DOI: 10.1039/C4CE01404A

pH controlled adsorption of water-soluble ruthenium clusters onto carbon nanotubes and nanofiber surfaces
Nathalie Mager, Wouter S. Lamme, Samuel Carlier and Sophie Hermans
Phys. Chem. Chem. Phys., 2016, 18, 32210
DOI: 10.1039/C6CP05314A

Designing organometallic compounds for catalysis and therapy
Anna Louisa Noffke, Abraha Habtemariam, Ana M. Pizarro and Peter J. Sadler
Chem. Commun., 2012, 48, 5219
DOI: 10.1039/c2cc30678f

The role of ancillary ligands on benzodipyridophenazine-based Ru(ii)/Ir(iii) complexes in dark and light toxicity against TNBC cells
Nivedya T., Rishav Das, Selva Kumar R., Shanooja Shanavas, Bhaskar Rangaswamy, Mujthaba Aatif A, Chandrapaul Mukherjee, Riona Roy, Jhimli Sengupta, Bipasha Bose, Ashok Kumar S. K. and Priyankar Paira
Dalton Trans., 2025, 54, 4888
DOI: 10.1039/D4DT03456B

Acid-assisted hydrogenation of CO2 to methanol using Ru(ii) and Rh(iii) RAPTA-type catalysts under mild conditions
Manoj Trivedi, Pooja Sharma, Indresh Kumar Pandey, Abhinav Kumar, Sanjay Kumar and Nigam P. Rath
Chem. Commun., 2021, 57, 8941
DOI: 10.1039/D1CC03049C

Synthesis and anticancer activity evaluation of η5-C5(CH3)4R ruthenium complexes bearing chelating diphosphine ligands
A. Rodríguez-Bárzano, R. M. Lord, A. M. Basri, R. M. Phillips, A. J. Blacker and P. C. McGowan
Dalton Trans., 2015, 44, 3265
DOI: 10.1039/C4DT02748E

A Ru(ii)-arene-ferrocene complex with promising antibacterial activity
Stephen Mensah, Joseph D. Rosenthal, Mamta Dagar, Tyson Brown, Jonathan J. Mills, Christopher G. Hamaker, Gregory M. Ferrence and Michael I. Webb
Dalton Trans., 2022, 51, 17609
DOI: 10.1039/D2DT02696A

Multifaceted half-sandwich arene–ruthenium complexes: interactions with biomolecules, photoactivation, and multinuclearity approach
Sanjay Kumar Singh and Daya Shankar Pandey
RSC Adv., 2014, 4, 1819
DOI: 10.1039/C3RA44131H

A categorization of metal anticancer compounds based on their mode of action
Teresa Gianferrara, Ioannis Bratsos and Enzo Alessio
Dalton Trans., 2009, 7588
DOI: 10.1039/b905798f

Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
Alberta Bergamo and Gianni Sava
Dalton Trans., 2011, 40, 7817
DOI: 10.1039/c0dt01816c

Investigating the reactivity of neutral water-soluble Ru(ii)–PTA carbonyls towards the model imine ligands pyridine and 2,2′-bipyridine
Federica Battistin, Alessio Vidal, Gabriele Balducci and Enzo Alessio
RSC Adv., 2020, 10, 26717
DOI: 10.1039/D0RA05898J

Areneruthenium complexes as anticancer agents
Georg Süss-Fink
Dalton Trans., 2010, 39, 1673
DOI: 10.1039/B916860P

Ruthenium(ii) arene PTA (RAPTA) complexes: impact of enantiomerically pure chiral ligands
Kelly J. Kilpin, Shona M. Cammack, Catherine M. Clavel and Paul J. Dyson
Dalton Trans., 2013, 42, 2008
DOI: 10.1039/C2DT32333H

Design, synthesis, characterisation and chemical reactivity of mixed-ligand platinum(ii) oxadiazoline complexes with potential cytotoxic properties
Gabriele Wagner, Anthony Marchant and James Sayer
Dalton Trans., 2010, 39, 7747
DOI: 10.1039/c0dt00360c

Cellular delivery of pyrenyl-arene ruthenium complexes by a water-soluble arene ruthenium metalla-cage
Mona Anca Furrer, Frédéric Schmitt, Michaël Wiederkehr, Lucienne Juillerat-Jeanneret and Bruno Therrien
Dalton Trans., 2012, 41, 7201
DOI: 10.1039/c2dt30193h

Rationalization of the inhibition activity of structurally related organometallic compounds against the drug target cathepsin B by DFT
Angela Casini, Fabio Edafe, Mikael Erlandsson, Luca Gonsalvi, Antonella Ciancetta, Nazzareno Re, Andrea Ienco, Luigi Messori, Maurizio Peruzzini and Paul J. Dyson
Dalton Trans., 2010, 39, 5556
DOI: 10.1039/c003218b

3-Hydroxyflavones vs. 3-hydroxyquinolinones: structure–activity relationships and stability studies on RuII(arene) anticancer complexes with biologically active ligands
Andrea Kurzwernhart, Wolfgang Kandioller, Éva A. Enyedy, Maria Novak, Michael A. Jakupec, Bernhard K. Keppler and Christian G. Hartinger
Dalton Trans., 2013, 42, 6193
DOI: 10.1039/C2DT32206D

Cationic arene ruthenium(ii) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents
Gerd Ludwig, Goran N. Kaluđerović, Tobias Rüffer, Martin Bette, Marcus Korb, Michael Block, Reinhard Paschke, Heinrich Lang and Dirk Steinborn
Dalton Trans., 2013, 42, 3771
DOI: 10.1039/c3dt33064h

The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials
Leli Zeng, Pranav Gupta, Yanglu Chen, Enju Wang, Liangnian Ji, Hui Chao and Zhe-Sheng Chen
Chem. Soc. Rev., 2017, 46, 5771
DOI: 10.1039/C7CS00195A

DNA binding selectivity of oligopyridine-ruthenium(ii)-lysine conjugate
Katelitsa Triantafillidi, Konstantina Karidi, Olga Novakova, Jaroslav Malina and Achilleas Garoufis
Dalton Trans., 2011, 40, 472
DOI: 10.1039/C0DT00554A

Supramolecular architectures based on p-cymene/ruthenium complexes functionalized with nucleobases
Fabio Sce, Garikoitz Beobide, Oscar Castillo, Imanol de Pedro, Sonia Pérez-Yáñez and Efraim Reyes
CrystEngComm, 2017, 19, 6039
DOI: 10.1039/C7CE01496A

A contribution to the rational design of Ru(CO)3Cl2L complexes for in vivo delivery of CO
João D. Seixas, Marino F. A. Santos, Abhik Mukhopadhyay, Ana C. Coelho, Patrícia M. Reis, Luís F. Veiros, Ana R. Marques, Nuno Penacho, Ana M. L. Gonçalves, Maria J. Romão, Gonçalo J. L. Bernardes, Teresa Santos-Silva and Carlos C. Romão
Dalton Trans., 2015, 44, 5058
DOI: 10.1039/C4DT02966F

Versatile coordination of acetazolamide to ruthenium(ii) p-cymene complexes and preliminary cytotoxicity studies
Lorenzo Biancalana, Lucinda K. Batchelor, Gianluca Ciancaleoni, Stefano Zacchini, Guido Pampaloni, Paul J. Dyson and Fabio Marchetti
Dalton Trans., 2018, 47, 9367
DOI: 10.1039/C8DT01555D

Macromolecular ruthenium complexes as anti-cancer agents
Bianca M. Blunden, Donald S. Thomas and Martina H. Stenzel
Polym. Chem., 2012, 3, 2964
DOI: 10.1039/c2py20439h

Selectivity for TP53 signalling drives the mode of action of a highly potent N,O,O-tridentate naphthoquinone-based organo-ruthenium anticancer drug candidate
Alexander Rosner, Lukas Skos, Theresa Mendrina, Dina Baier, Michaela Hejl, Yasmin Borutzki, Mathias Gradl, Heiko Geisler, Thomas Mohr, Anton Legin, Michael A. Jakupec, Andrea Bileck, Christopher Gerner, Gunda Koellensperger, Petra Heffeter, Walter Berger, Bernhard K. Keppler, Wolfgang Kandioller and Samuel M. Meier-Menches
Chem. Sci., 2025
DOI: 10.1039/D5SC00735F

Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects
Anne Vessières, Siden Top, Wolfgang Beck, Elizabeth Hillard and Gérard Jaouen
Dalton Trans., 2006, 529
DOI: 10.1039/B509984F

Pseudo electron-deficient organometallics: limited reactivity towards electron-donating ligands
Anaïs Pitto-Barry, Alexandru Lupan, Markus Zegke, Thomas Swift, Amr A. A. Attia, Rianne M. Lord and Nicolas P. E. Barry
Dalton Trans., 2017, 46, 15676
DOI: 10.1039/C7DT02827J

Anti-cancer organoruthenium(ii) complexes and their interactions with cysteine and its analogues. A mass-spectrometric study
Anamarija Briš, Juraj Jašík, Iztok Turel and Jana Roithová
Dalton Trans., 2019, 48, 2626
DOI: 10.1039/C8DT04350G

Addition of ethynylferrocene to transition-metal complexes containing a chelating 1,2-dicarba-closo-dodecaborane-1,2-dichalcogenolate ligand—in vitro cooperativity of a ruthenium compound on cellular uptake of an anticancer drug
De-Hong Wu, Chun-Hui Wu, Yi-Zhi Li, Da-Dong Guo, Xue-Mei Wang and Hong Yan
Dalton Trans., 2009, 285
DOI: 10.1039/B810831E

Metal–organic frameworks as potential multi-carriers of drugs
Sara Rojas, Paul S. Wheatley, Elsa Quartapelle-Procopio, Barbara Gil, Bartosz Marszalek, Russell E. Morris and Elisa Barea
CrystEngComm, 2013, 15, 9364
DOI: 10.1039/c3ce41289j

Dicarba-closo-dodecarborane-containing half-sandwich complexes of ruthenium, osmium, rhodium and iridium: biological relevance and synthetic strategies
Nicolas P. E. Barry and Peter J. Sadler
Chem. Soc. Rev., 2012, 41, 3264
DOI: 10.1039/c2cs15300a

Hydrolytic behaviour of mono- and dithiolato-bridged dinuclear arene ruthenium complexes and their interactions with biological ligands
David Stíbal, Lennart Geiser, Georg Süss-Fink and Julien Furrer
RSC Adv., 2016, 6, 38332
DOI: 10.1039/C6RA07701C

Discovery of a dual-targeting organometallic ruthenium complex with high activity inducing early stage apoptosis of cancer cells
Jun Du, Erlong Zhang, Yao Zhao, Wei Zheng, Yang Zhang, Yu Lin, Zhaoying Wang, Qun Luo, Kui Wu and Fuyi Wang
Metallomics, 2015, 7, 1573
DOI: 10.1039/C5MT00122F

Highly cytotoxic diruthenium trithiolato complexes of the type [(η6-p-MeC6H4Pri)2Ru2(μ2-SR)3]+: synthesis, characterization, molecular structure and in vitro anticancer activity
Federico Giannini, Lydia E. H. Paul, Julien Furrer, Bruno Therrien and Georg Süss-Fink
New J. Chem., 2013, 37, 3503
DOI: 10.1039/c3nj00476g

Novel “ruthenium cyclopentadienyl”–peptide conjugate complexes against human FGFR(+) breast cancer
João Franco Machado, Miguel Machuqueiro, Fernanda Marques, M. Paula Robalo, M. Fátima M. Piedade, M. Helena Garcia, João D. G. Correia and Tânia S. Morais
Dalton Trans., 2020, 49, 5974
DOI: 10.1039/D0DT00955E

Ruthenium(ii) complex of 2-(9-anthryl)-1H-imidazo[4,5-f][1,10]phenanthroline: synthesis, spectrophotometric pH titrations and DNA interaction
Mei-Jiao Han, Li-Hua Gao and Ke-Zhi Wang
New J. Chem., 2006, 30, 208
DOI: 10.1039/B511358J

16  The noble metals
Peter Thornton
Annu. Rep. Prog. Chem., Sect. A: Inorg. Chem., 2002, 98, 235
DOI: 10.1039/B109613N

Tuning the cytotoxicity of ruthenium(ii) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand
Lorenzo Biancalana, Stefano Zacchini, Nicola Ferri, Maria Giovanna Lupo, Guido Pampaloni and Fabio Marchetti
Dalton Trans., 2017, 46, 16589
DOI: 10.1039/C7DT03385K

Ruthenium arene complexes with triphenylphosphane ligands: cytotoxicity towards pancreatic cancer cells, interaction with model proteins, and effect of ethacrynic acid substitution
Lorenzo Biancalana, Alessandro Pratesi, Federica Chiellini, Stefano Zacchini, Tiziana Funaioli, Chiara Gabbiani and Fabio Marchetti
New J. Chem., 2017, 41, 14574
DOI: 10.1039/C7NJ02300F

Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development
Samuel M. Meier-Menches, Christopher Gerner, Walter Berger, Christian G. Hartinger and Bernhard K. Keppler
Chem. Soc. Rev., 2018, 47, 909
DOI: 10.1039/C7CS00332C

Ruthenium(ii) arene complexes showing DNA photobinding: the role of the basicity of the monodentate ligand
Yongjie Chen, Xiaohe Luo, Lijuan Bai, Xuelian Hu, Jing Zhou, Pu Zhang and Yu Yu
New J. Chem., 2017, 41, 10225
DOI: 10.1039/C7NJ01864A

Novel metal(ii) arene 2-pyridinecarbothioamides: a rationale to orally active organometallic anticancer agents
Samuel M. Meier, Muhammad Hanif, Zenita Adhireksan, Verena Pichler, Maria Novak, Elisabeth Jirkovsky, Michael A. Jakupec, Vladimir B. Arion, Curt A. Davey, Bernhard K. Keppler and Christian G. Hartinger
Chem. Sci., 2013, 4, 1837
DOI: 10.1039/c3sc22294b

RAPTA-C incorporation and controlled delivery from MIL-100(Fe) nanoparticles
Sara Rojas, Francisco J. Carmona, Carmen R. Maldonado, Elisa Barea and Jorge A. R. Navarro
New J. Chem., 2016, 40, 5690
DOI: 10.1039/C5NJ02741A

Ruthenium(ii) complexes of 6-hydroxydipyrido[3,2-a:2′,3′-c]phenazine: self-association, and concentration-dependent acid–base and DNA-binding properties
Mei-Jiao Han, Yan-Min Chen and Ke-Zhi Wang
New J. Chem., 2008, 32, 970
DOI: 10.1039/b711759k

Metallomic study on the metabolism of RAPTA-C and cisplatin in cell culture medium and its impact on cell accumulation
Hannah U. Holtkamp, Sanam Movassaghi, Stuart J. Morrow, Mario Kubanik and Christian G. Hartinger
Metallomics, 2018, 10, 455
DOI: 10.1039/C8MT00024G

Synthesis, molecular structure and evaluation of new organometallic ruthenium anticancer agents
Kenneth D. Camm, Ahmed El-Sokkary, Andrew L. Gott, Peter G. Stockley, Tamara Belyaeva and Patrick C. McGowan
Dalton Trans., 2009, 10914
DOI: 10.1039/b918902e

Ruthenium-catalyzed synthesis of β-oxo esters in aqueous medium: Scope and limitations
Victorio Cadierno, Javier Francos and José Gimeno
Green Chem., 2010, 12, 135
DOI: 10.1039/B914774H

Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action
Maria V. Babak, Samuel M. Meier, Kilian V. M. Huber, Jóhannes Reynisson, Anton A. Legin, Michael A. Jakupec, Alexander Roller, Alexey Stukalov, Manuela Gridling, Keiryn L. Bennett, Jacques Colinge, Walter Berger, Paul J. Dyson, Giulio Superti-Furga, Bernhard K. Keppler and Christian G. Hartinger
Chem. Sci., 2015, 6, 2449
DOI: 10.1039/C4SC03905J

Half-sandwich arene ruthenium(ii)–enzyme complex
Iain W. McNae, Katy Fishburne, Abraha Habtemariam, Tina M. Hunter, Michael Melchart, Fuyi Wang, Malcolm D. Walkinshaw and Peter J. Sadler
Chem. Commun., 2004, 1786
DOI: 10.1039/B408141B

Structural analysis of ruthenium–arene complexes using ion mobility mass spectrometry, collision-induced dissociation, and DFT
Izabella Czerwinska, Johann Far, Christopher Kune, Carlos Larriba-Andaluz, Lionel Delaude and Edwin De Pauw
Dalton Trans., 2016, 45, 6361
DOI: 10.1039/C6DT00080K

Reactions of an organoruthenium anticancer complex with 2-mercaptobenzanilide—a model for the active-site cysteine of protein tyrosine phosphatase 1B
Yumiao Han, Qun Luo, Xiang Hao, Xianchan Li, Fuyi Wang, Wenbing Hu, Kui Wu, Shuang Lü and Peter J. Sadler
Dalton Trans., 2011, 40, 11519
DOI: 10.1039/c1dt11189b

Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents
Michaël Gras, Bruno Therrien, Georg Süss-Fink, Olivier Zava and Paul J. Dyson
Dalton Trans., 2010, 39, 10305
DOI: 10.1039/c0dt00887g

Counterion-dependent deuteration of pentamethylcyclopentadiene in water-soluble cationic Rh(iii) complexes assisted by PTA
Gianluca Ciancaleoni, Sandra Bolaño, Jorge Bravo, Maurizio Peruzzini, Luca Gonsalvi and Alceo Macchioni
Dalton Trans., 2010, 39, 3366
DOI: 10.1039/c003056m

Water soluble derivatives of platinum carbonyl Chini clusters: synthesis, molecular structures and cytotoxicity of [Pt12(CO)20(PTA)4]2−and [Pt15(CO)25(PTA)5]2− 
Lucinda K. Batchelor, Beatrice Berti, Cristiana Cesari, Iacopo Ciabatti, Paul J. Dyson, Cristina Femoni, Maria C. Iapalucci, Matteo Mor, Silvia Ruggieri and Stefano Zacchini
Dalton Trans., 2018, 47, 4467
DOI: 10.1039/C8DT00228B

Role of the (pseudo)halido ligand in ruthenium(ii) p-cymene α-amino acid complexes in speciation, protein reactivity and cytotoxicity
Lorenzo Biancalana, Emanuele Zanda, Mouna Hadiji, Stefano Zacchini, Alessandro Pratesi, Guido Pampaloni, Paul J. Dyson and Fabio Marchetti
Dalton Trans., 2021, 50, 15760
DOI: 10.1039/D1DT03274G

A new 3D organotypic model of ovarian cancer to help evaluate the antimetastatic activity of RAPTA-C conjugated micelles
Mingxia Lu, Claire E. Henry, Haiwang Lai, Yee Yee Khine, Caroline E. Ford and Martina H. Stenzel
Biomater. Sci., 2019, 7, 1652
DOI: 10.1039/C8BM01326H

Unexpected arene ligand exchange results in the oxidation of an organoruthenium anticancer agent: the first X-ray structure of a protein–Ru(carbene) adduct
Matthew P. Sullivan, Michél K. Nieuwoudt, Graham A. Bowmaker, Nelson Y. S. Lam, Dianna Truong, David C. Goldstone and Christian G. Hartinger
Chem. Commun., 2018, 54, 6120
DOI: 10.1039/C8CC02433B

A comprehensive review of caged phosphines: synthesis, catalytic applications, and future perspectives
Harshita Shet, Udaysinh Parmar, Shatrughn Bhilare and Anant R. Kapdi
Org. Chem. Front., 2021, 8, 1599
DOI: 10.1039/D0QO01194K

Increasing the selectivity of biologically active tetranuclear arene ruthenium assemblies
Gajendra Gupta, Patrycja Nowak-Sliwinska, Noelia Herrero, Paul J. Dyson and Bruno Therrien
Journal of Organometallic Chemistry, 2015, 796, 59
DOI: 10.1016/j.jorganchem.2015.02.004

Factors affecting nucleolytic efficiency of some ternary metal complexes with DNA binding and recognition domains. Crystal and molecular structure of Zn(phen)(edda)
Hoi-Ling Seng, Han-Kiat Alan Ong, Raja Noor Zaliha Raja Abd. Rahman, Bohari M. Yamin, Edward R.T. Tiekink, Kong Wai Tan, Mohd Jamil Maah, Ignez Caracelli and Chew Hee Ng
Journal of Inorganic Biochemistry, 2008, 102, 1997
DOI: 10.1016/j.jinorgbio.2008.07.015

Azaindoles: Suitable ligands of cytotoxic transition metal complexes
Pavel Štarha and Zdeněk Trávníček
Journal of Inorganic Biochemistry, 2019, 197, 110695
DOI: 10.1016/j.jinorgbio.2019.110695

Synthesis and Structural and Spectroscopic Characterization of New RuII‐dmso Precursors with Face‐Capping Ligands for Use in Self‐Assembly Reactions
Elisabetta Iengo, Ennio Zangrando, Edi Baiutti, Fabio Munini and Enzo Alessio
Eur J Inorg Chem, 2005, 2005, 1019
DOI: 10.1002/ejic.200400717

Design of organoruthenium complexes for nanoparticle functionalization
Saawan Kumar, Guillaume Gallician, Dennis Weidener, Matthew P. Sullivan, Tilo Söhnel, Muhammad Hanif and Christian G. Hartinger
Journal of Organometallic Chemistry, 2019, 891, 64
DOI: 10.1016/j.jorganchem.2019.03.020

Ruthenium(II) Complex of Hbopip:  Synthesis, Characterization, pH-Induced Luminescence “Off−On−Off” Switch, and Avid Binding to DNA
Mei-Jiao Han, Li-Hua Gao, Yuan-Yuan Lü and Ke-Zhi Wang
J. Phys. Chem. B, 2006, 110, 2364
DOI: 10.1021/jp0548570

Analysis of Coordination and Organometallic Compounds Using Photoionisation Mass Spectrometric Techniques
Antoine Dorcier, Paul J. Dyson and J. Scott McIndoe
Eur J Inorg Chem, 2003, 2003, 4294
DOI: 10.1002/ejic.200300459

The impact of ion pair association upon the 1H NMR spectra of cationic complexes akin to Grubbs catalysts
Günter Paulus Schiemenz
Magnetic Reson in Chemistry, 2010, 48, 261
DOI: 10.1002/mrc.2570

Novel microwave synthesis of half‐sandwich [(η6‐C6H6)Ru] complexes and an evaluation of the biological activity and biochemical reactivity
Floyd A. Beckford, Alyssa Stott, Antonio Gonzalez‐Sarrías and Navindra P. Seeram
Applied Organom Chemis, 2013, 27, 425
DOI: 10.1002/aoc.3007

In Vitro Evaluation of Rhodium and Osmium RAPTA Analogues:  The Case for Organometallic Anticancer Drugs Not Based on Ruthenium
Antoine Dorcier, Wee Han Ang, Sandra Bolaño, Luca Gonsalvi, Lucienne Juillerat-Jeannerat, Gàbor Laurenczy, Maurizio Peruzzini, Andrew D. Phillips, Fabrizio Zanobini and Paul J. Dyson
Organometallics, 2006, 25, 4090
DOI: 10.1021/om060394o

Luminescent Piano-Stool Complexes Incorporating 1-(4-Cyanophenyl)imidazole: Synthesis, Spectral, and Structural Studies
Sanjay K. Singh, Manoj Trivedi, M. Chandra, Abhaya N. Sahay and Daya Shankar Pandey
Inorg. Chem., 2004, 43, 8600
DOI: 10.1021/ic049256m

Catalysis of redox isomerization of allylic alcohols by [RuClCp(mPTA)2](OSO2CF3)2 and [RuCp(mPTA)2(OH2-κO)](OSO2CF3)3·(H2O)(C4H10O)0.5. Unusual influence of the pH and interaction of phosphate with catalyst on the reaction rate
Beatríz González, Pablo Lorenzo-Luis, Manuel Serrano-Ruiz, Éva Papp, Marianna Fekete, Klára Csépke, Katalin Ősz, Ágnes Kathó, Ferenc Joó and Antonio Romerosa
Journal of Molecular Catalysis A: Chemical, 2010, 326, 15
DOI: 10.1016/j.molcata.2010.05.003

Arene ruthenium dithiolato–carborane complexes for boron neutron capture therapy (BNCT)
Isolda Romero-Canelón, Ben Phoenix, Anaïs Pitto-Barry, Johanna Tran, Joan J. Soldevila-Barreda, Nigel Kirby, Stuart Green, Peter J. Sadler and Nicolas P.E. Barry
Journal of Organometallic Chemistry, 2015, 796, 17
DOI: 10.1016/j.jorganchem.2015.05.011

Organometallic complexes that interconvert between trimeric and monomeric structures as a function of pH and their effect on human cancer and fibroblast cells
Wee Han Ang, Zacharias Grote, Rosario Scopelliti, Lucienne Juillerat-Jeanneret, Kay Severin and Paul J. Dyson
Journal of Organometallic Chemistry, 2009, 694, 968
DOI: 10.1016/j.jorganchem.2008.11.026

Anti-metastasis and anti-proliferation effect of mitochondria-accumulating ruthenium(II) complexes via redox homeostasis disturbance and energy depletion
Lina Xie, Lili Wang, Ruilin Guan, Liangnian Ji and Hui Chao
Journal of Inorganic Biochemistry, 2021, 217, 111380
DOI: 10.1016/j.jinorgbio.2021.111380

Highly active neutral ruthenium(II) arene complexes: Synthesis, characterization, and investigation of their anticancer properties
Gerd Ludwig, Goran N. Kaluđerović, Martin Bette, Michael Block, Reinhard Paschke and Dirk Steinborn
Journal of Inorganic Biochemistry, 2012, 113, 77
DOI: 10.1016/j.jinorgbio.2012.04.003

Chemistry and reactivity of ruthenium(II) complexes: DNA/protein binding mode and anticancer activity are related to the complex structure
Ana Rilak Simović, Romana Masnikosa, Ioannis Bratsos and Enzo Alessio
Coordination Chemistry Reviews, 2019, 398, 113011
DOI: 10.1016/j.ccr.2019.07.008

In-vitro and in-vivo evaluation of the anticancer activity of diruthenium-2, a new trithiolato arene ruthenium complex [(η6-p-MeC6H4Pr i )2Ru2(μ-S-p-C6H4OH)3]Cl
Darina Muthná, Pavel Tomšík, Radim Havelek, Renata Köhlerová, Vidhya Kasilingam, Eva Čermáková, David Stíbal, Martina Řezáčová and Georg Süss-Fink
Anti-Cancer Drugs, 2016, 27, 643
DOI: 10.1097/CAD.0000000000000374

The effects of linear assembly of two carbazole groups on acid–base and DNA-binding properties of a ruthenium(II) complex
Xi Chen, Long-Xin Xue, Chun-Chuan Ju and Ke-Zhi Wang
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2013, 111, 196
DOI: 10.1016/j.saa.2013.04.017

Tuning the Efficacy of Ruthenium(II)-Arene (RAPTA) Antitumor Compounds with Fluorinated Arene Ligands
Anna K. Renfrew, Andrew D. Phillips, Enrico Tapavicza, Rosario Scopelliti, Ursula Rothlisberger and Paul J. Dyson
Organometallics, 2009, 28, 5061
DOI: 10.1021/om900345n

Arene ruthenium dichloro complexes containing isonicotinic ester ligands: Synthesis, molecular structure and cytotoxicity
Farooq-Ahmad Khan, Bruno Therrien, Georg Süss-Fink, Olivier Zava and Paul J. Dyson
Journal of Organometallic Chemistry, 2013, 730, 49
DOI: 10.1016/j.jorganchem.2012.10.016

Catalytic racemization of secondary alcohols with new (arene)Ru(II)-NHC and (arene)Ru(II)-NHC-tertiary phosphine complexes
Natália Marozsán, Henrietta Horváth, Éva Kováts, Antal Udvardy, Anikó Erdei, Mihály Purgel and Ferenc Joó
Molecular Catalysis, 2018, 445, 248
DOI: 10.1016/j.mcat.2017.11.040

Synthesis and Characterization of New Water‐Soluble Hydrides of RuII: A Step towards Dinitrogen Activation?
Maxime Loy and Gábor Laurenczy
Helvetica Chimica Acta, 2005, 88, 557
DOI: 10.1002/hlca.200590038

Physicochemical Studies and Anticancer Potency of Ruthenium η6-p-Cymene Complexes Containing Antibacterial Quinolones
Jakob Kljun, Anna K. Bytzek, Wolfgang Kandioller, Caroline Bartel, Michael A. Jakupec, Christian G. Hartinger, Bernhard K. Keppler and Iztok Turel
Organometallics, 2011, 30, 2506
DOI: 10.1021/om101180c

Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(η6-p-phenylethacrynate)Cl2(pta)]
Korawan Chakree, Chitchamai Ovatlarnporn, Paul Dyson and Adisorn Ratanaphan
IJMS, 2012, 13, 13183
DOI: 10.3390/ijms131013183

Ionic mononuclear [Fe] and heterodinuclear [Fe,Ru] bis(diphenylphosphino)alkane complexes: Synthesis, spectroscopy, DFT structures, cytotoxicity, and biomolecular interactions
Matylda Odachowski, Robin Neven, Giuditta Perversi, Dario Romano, Cathryn A. Slabber, Mouna Hadiji, Maarten Honing, Yuandi Zhao, Orde Q. Munro and Burgert Blom
Journal of Inorganic Biochemistry, 2023, 242, 112156
DOI: 10.1016/j.jinorgbio.2023.112156

Anticancer Ruthenium(III) Complex KP1019 Interferes with ATP‐Dependent Ca2+Translocation by Sarco‐Endoplasmic Reticulum Ca2+‐ATPase (SERCA)
Fabrizio‐Zagros Sadafi, Lara Massai, Gianluca Bartolommei, Maria Rosa Moncelli, Luigi Messori and Francesco Tadini‐Buoninsegni
ChemMedChem, 2014, 9, 1660
DOI: 10.1002/cmdc.201402128

Insights into the in vitro Anticancer Effects of Diruthenium‐1
Aneta Koceva‐Chyła, Karolina Matczak, Msc. Paweł Hikisz, Msc. Kamil Durka, Msc. Krzysztof Kochel, Georg Süss‐Fink, Julien Furrer and Konrad Kowalski
ChemMedChem, 2016, 11, 2171
DOI: 10.1002/cmdc.201600315

Extrapolating the Fragment-Based Approach to Inorganic Drug Discovery
Lucinda K. Batchelor and Paul J. Dyson
Trends in Chemistry, 2019, 1, 644
DOI: 10.1016/j.trechm.2019.05.001

Half-sandwich late transition metal complexes based on functionalized carborane ligands
Zi-Jian Yao and Wei Deng
Coordination Chemistry Reviews, 2016, 309, 21
DOI: 10.1016/j.ccr.2015.10.008

Minor Modifications to the Ligands Surrounding a Ruthenium Complex Lead to Major Differences in the Way in which they Catalyse the Hydrogenation of Arenes
Paul J. Dyson, David J. Ellis and Gábor Laurenczy
Adv Synth Catal, 2003, 345, 211
DOI: 10.1002/adsc.200390014

2-Thia-1,3,5-triaza-7-phosphaadamantane-2,2-dioxide Revisited: Computational and Experimental Studies of a Neglected Phosphine
Michelle Sternberg, Cherumuttathu H. Suresh and Fabian Mohr
Organometallics, 2010, 29, 3922
DOI: 10.1021/om100579e

Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
Patrycja Nowak-Sliwinska, Judy R. van Beijnum, Angela Casini, Alexey A. Nazarov, Georges Wagnières, Hubert van den Bergh, Paul J. Dyson and Arjan W. Griffioen
J. Med. Chem., 2011, 54, 3895
DOI: 10.1021/jm2002074

Structure and function in organometallic•protein complexes
Richard S. Herrick, Christopher J. Ziegler and Thomas C. Leeper
Journal of Organometallic Chemistry, 2014, 751, 90
DOI: 10.1016/j.jorganchem.2013.07.004

N‐Heterocyclic Carbene Complexes RuII(Arene) and their Application as ROMP Catalysts, Antioxidant and Anticancer Agents
Rubina Troiano, Domenico Iacopetta, Assunta D'Amato, Annaluisa Mariconda, Jessica Ceramella, Alessia Catalano, Maria Stefania Sinicropi and Pasquale Longo
Eur J Inorg Chem, 2024, 27
DOI: 10.1002/ejic.202400402

Oxygen Transfer Reactions. 4. Reaction of High Valent Oxoruthenium Compounds with Sulfides
Sheng Lai, Carmela Jackson Lepage and Donald G. Lee
Inorg. Chem., 2002, 41, 1954
DOI: 10.1021/ic0108336

Control of Reversible Activation Dynamics of [Ru{η6:κ1‐C6H5(C6H4)NH2}(XY)]n+ and the Effect of Chelating‐Ligand Variation
Francisco Martínez‐Peña and Ana M. Pizarro
Chemistry A European J, 2017, 23, 16231
DOI: 10.1002/chem.201701681

Cobalt and Zinc Compounds Bearing 1,10‐Phenanthroline‐5,6‐dione or 1,3,5‐Triaza‐7‐phosphaadamantane Derivatives – Synthesis, Characterization, Cytotoxicity, and Cell Selectivity Studies
Telma F. S. Silva, Piotr Smoleński, Luísa M. D. R. S. Martins, M. Fátima C. Guedes da Silva, Alexandra R. Fernandes, Daniel Luis, Ana Silva, Susana Santos, Pedro M. Borralho, Cecília M. P. Rodrigues and Armando J. L. Pombeiro
Eur J Inorg Chem, 2013, 2013, 3651
DOI: 10.1002/ejic.201300197

Multi-targeted organometallic ruthenium(II)–arene anticancer complexes bearing inhibitors of poly(ADP-ribose) polymerase-1: A strategy to improve cytotoxicity
Zhigang Wang, Hui Qian, Shek-Man Yiu, Jianwei Sun and Guangyu Zhu
Journal of Inorganic Biochemistry, 2014, 131, 47
DOI: 10.1016/j.jinorgbio.2013.10.017

Ionic and Neutral Half‐Sandwich Guanidinatoruthenium(II) Complexes and Their Solution Behavior
Ram Kishan, Robin Kumar, Sambath Baskaran, Chinnappan Sivasankar and Natesan Thirupathi
Eur J Inorg Chem, 2015, 2015, 3182
DOI: 10.1002/ejic.201500395

Acetal-Functionalized RAPTA Complexes for Conjugation and Labeling
Yu Qian Tan, Paul J. Dyson and Wee Han Ang
Organometallics, 2011, 30, 5965
DOI: 10.1021/om200783r

Arene Ruthenium(II) Complexes Bearing the κ-P or κ-P,κ-S Ph2P(CH2)3SPh Ligand
Sören Arlt, Vladana Petković, Gerd Ludwig, Thomas Eichhorn, Heinrich Lang, Tobias Rüffer, Sanja Mijatović, Danijela Maksimović-Ivanić and Goran N. Kaluđerović
Molecules, 2021, 26, 1860
DOI: 10.3390/molecules26071860

Influence of Protonation State on the Excited State Dynamics of a Photobiologically Active Ru(II) Dyad
Christian Reichardt, Tariq Sainuddin, Maria Wächtler, Susan Monro, Stephan Kupfer, Julien Guthmuller, Stefanie Gräfe, Sherri McFarland and Benjamin Dietzek
J. Phys. Chem. A, 2016, 120, 6379
DOI: 10.1021/acs.jpca.6b05957

PTABS: A Unique Water-Soluble π-Acceptor Caged Phosphine
Rajesh Sahu and Anant R. Kapdi
Synlett, 2023, 34, 912
DOI: 10.1055/a-1988-1861

New highly water-soluble rhodium complexes bearing 1,3,5-triaza-7-phosphaadamantane (PTA) and/or tris(hydroxymethyl) phosphine (THP)
Sandra Bolaño, Maider Plaza, Jorge Bravo, Jesús Castro, Maurizio Peruzzini, Luca Gonsalvi, Gianluca Ciancaleoni and Alceo Macchioni
Inorganica Chimica Acta, 2010, 363, 509
DOI: 10.1016/j.ica.2009.05.041

Design of neutral, mono- or di-cationic water-soluble trihydrazidophosphoradamantanes
Maria Zabłocka and Carine Duhayon
Tetrahedron Letters, 2006, 47, 2687
DOI: 10.1016/j.tetlet.2006.02.096

Nanoscaled Zinc Pyrazolate Metal–Organic Frameworks as Drug-Delivery Systems
Sara Rojas, Francisco J. Carmona, Carmen R. Maldonado, Patricia Horcajada, Tania Hidalgo, Christian Serre, Jorge A. R. Navarro and Elisa Barea
Inorg. Chem., 2016, 55, 2650
DOI: 10.1021/acs.inorgchem.6b00045

Palladium(II)‐Imidoyl Complexes: A New Piece in the Puzzle of Organopalladium Anticancer Agents
Enrica Bortolamiol, Sofia Novaselich, Chiara Tupini, Sofia Fagnani, Roberto Gambari, Nicola Demitri, Ilaria Lampronti, Fabiano Visentin and Thomas Scattolin
Eur J Inorg Chem, 2024, 27
DOI: 10.1002/ejic.202300673

Syntheses and characterization of arene ruthenium (II) complexes containing N,N′-donor Schiff base ligands. Crystal and molecular structure of [(η6-C6Me6)Ru(C5H4N-2-CHNC6H4-p-NO2)]PF6
R. Lalrempuia, Mohan Rao Kollipara and Patrick J. Carroll
Polyhedron, 2003, 22, 605
DOI: 10.1016/S0277-5387(02)01430-4

New Synthetic Pathways ofcis- ortrans-Hydroxytamoxifen Derivatives with in Situ Formed [Cp*Rh(solvent)3]2+Complexes:  Kinetic and Thermodynamic Control, Including a Novel, Intramolecular N-π Rearrangement, and Relative Binding Affinities of the η6Complexes for the Estrogen Receptor
Siden Top, Anne Vessières, Gérard Jaouen and Richard H. Fish
Organometallics, 2006, 25, 3293
DOI: 10.1021/om060365d

Maltol‐Derived Ruthenium–Cymene Complexes with Tumor Inhibiting Properties: The Impact of Ligand–Metal Bond Stability on Anticancer Activity In Vitro
Wolfgang Kandioller, Christian G. Hartinger, Alexey A. Nazarov, Caroline Bartel, Matthias Skocic, Michael A. Jakupec, Vladimir B. Arion and Bernhard K. Keppler
Chemistry A European J, 2009, 15, 12283
DOI: 10.1002/chem.200901939

DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligands
Virtudes Moreno, Mercè Font-Bardia, Teresa Calvet, Julia Lorenzo, Francesc X. Avilés, M. Helena Garcia, Tânia S. Morais, Andreia Valente and M. Paula Robalo
Journal of Inorganic Biochemistry, 2011, 105, 241
DOI: 10.1016/j.jinorgbio.2010.10.009

A new amido-phosphine of dichloroacetic acid as an active ligand for metals of pharmaceutical interest. Synthesis, characterization and tests of antiproliferative and pro-apoptotic activity
Lorenza Marvelli, Valeria Ferretti, Valerio Bertolasi, Ilaria Lampronti, Roberto Gambari, Claudio Trapella, Giulia Turrin, Francesca Bonotto, Antonio Moriello and Paola Bergamini
Journal of Inorganic Biochemistry, 2019, 199, 110787
DOI: 10.1016/j.jinorgbio.2019.110787

Synthesis, characterization, molecular docking, and cytotoxicity study of ruthenium (II/III) polypyridyl complexes
Lebogang G. Julius, Daphne T. Mapolelo, Taye B. Demissie, Florence M. Nareetsile, Moses O. Koobotse, David O. Nkwe and James T. P. Matshwele
Applied Organom Chemis, 2024, 38
DOI: 10.1002/aoc.7341

Solvent-Dependent Hemilability of (2-Diphenylphosphino)Phenol in a Ru(II) para-Cymene System
Lorenzo Biancalana, Gianluca Ciancaleoni, Stefano Zacchini, Andrea Monti, Fabio Marchetti and Guido Pampaloni
Organometallics, 2018, 37, 1381
DOI: 10.1021/acs.organomet.8b00071

Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity
Zenita Adhireksan, Gabriela E. Davey, Pablo Campomanes, Michael Groessl, Catherine M. Clavel, Haojie Yu, Alexey A. Nazarov, Charmian Hui Fang Yeo, Wee Han Ang, Peter Dröge, Ursula Rothlisberger, Paul J. Dyson and Curt A. Davey
Nat Commun, 2014, 5
DOI: 10.1038/ncomms4462

Synthesis, molecular and electronic structures of half-sandwich ruthenium(II) complexes with pyrimidine-based ligands
J. G. Małecki
Transition Met Chem, 2010, 35, 801
DOI: 10.1007/s11243-010-9396-4

Synthesis and Anticancer Activity of Long-Chain Isonicotinic Ester Ligand-Containing Arene Ruthenium Complexes and Nanoparticles
Georg Süss-Fink, Farooq-Ahmad Khan, Lucienne Juillerat-Jeanneret, Paul J. Dyson and Anna K. Renfrew
J Clust Sci, 2010, 21, 313
DOI: 10.1007/s10876-010-0298-6

Curcumin-I Knoevenagel’s condensates and their Schiff’s bases as anticancer agents: Synthesis, pharmacological and simulation studies
Imran Ali, Ashanul Haque, Kishwar Saleem and Ming Fa Hsieh
Bioorganic & Medicinal Chemistry, 2013, 21, 3808
DOI: 10.1016/j.bmc.2013.04.018

New Class of Half-Sandwich Ruthenium(II) Arene Complexes Bearing the Water-Soluble CAP Ligand as an in Vitro Anticancer Agent
Antonella Guerriero, Werner Oberhauser, Tina Riedel, Maurizio Peruzzini, Paul J. Dyson and Luca Gonsalvi
Inorg. Chem., 2017, 56, 5514
DOI: 10.1021/acs.inorgchem.7b00915

Ruthenium(II)–Arene RAPTA Type Complexes Containing Curcumin and Bisdemethoxycurcumin Display Potent and Selective Anticancer Activity
Riccardo Pettinari, Fabio Marchetti, Francesca Condello, Claudio Pettinari, Giulio Lupidi, Rosario Scopelliti, Suman Mukhopadhyay, Tina Riedel and Paul J. Dyson
Organometallics, 2014, 33, 3709
DOI: 10.1021/om500317b

Proton Sponge Phosphanes: Reversibly Chargeable Ligands for ESI‐MS Analysis
Nicola J. Farrer, Krista L. Vikse, Robert McDonald and J. Scott McIndoe
Eur J Inorg Chem, 2012, 2012, 733
DOI: 10.1002/ejic.201100820

ESI–MS Characterisation of Protein Adducts of Anticancer Ruthenium(II)‐Arene PTA (RAPTA) Complexes
Angela Casini, Guido Mastrobuoni, Wee Han Ang, Chiara Gabbiani, Giuseppe Pieraccini, Gloriano Moneti, Paul J. Dyson and Luigi Messori
ChemMedChem, 2007, 2, 631
DOI: 10.1002/cmdc.200600258

Structure-Related Mode-of-Action Differences of Anticancer Organoruthenium Complexes with β-Diketonates
Sara Seršen, Jakob Kljun, Kushtrim Kryeziu, Rostyslav Panchuk, Beatrix Alte, Wilfried Körner, Petra Heffeter, Walter Berger and Iztok Turel
J. Med. Chem., 2015, 58, 3984
DOI: 10.1021/acs.jmedchem.5b00288

Synthesis and catalytic applications of Ru(II)-phosphaurotropine complexes with the use of simple water-soluble Ru(II)-precursors
Antal Udvardy, Ferenc Joó and Ágnes Kathó
Coordination Chemistry Reviews, 2021, 438, 213871
DOI: 10.1016/j.ccr.2021.213871

Synthetic and ESI mass spectrometric investigations of Pt, Pd, Ir, Ru and Rh complexes of a polyether-functionalised thiourea ligand
Haiming Tang, Onyekachi Raymond, Hayden P. Thomas and William Henderson
Transit Met Chem, 2022, 47, 169
DOI: 10.1007/s11243-022-00500-z

DNA Binding and Topoisomerase II Inhibitory Activity of Water-Soluble Ruthenium(II) and Rhodium(III) Complexes
Sanjay Kumar Singh, Shweta Joshi, Alok Ranjan Singh, Jitendra Kumar Saxena and Daya Shankar Pandey
Inorg. Chem., 2007, 46, 10869
DOI: 10.1021/ic700885m

Allosteric cross-talk in chromatin can mediate drug-drug synergy
Zenita Adhireksan, Giulia Palermo, Tina Riedel, Zhujun Ma, Reyhan Muhammad, Ursula Rothlisberger, Paul J. Dyson and Curt A. Davey
Nat Commun, 2017, 8
DOI: 10.1038/ncomms14860

DNA Interactions of Monofunctional Organometallic Osmium(II) Antitumor Complexes in Cell-Free Media
Hana Kostrhunova, Jakub Florian, Olga Novakova, Anna F. A. Peacock, Peter J. Sadler and Viktor Brabec
J. Med. Chem., 2008, 51, 3635
DOI: 10.1021/jm701538w

Modulating the Anticancer Activity of Ruthenium(II)–Arene Complexes
Catherine M. Clavel, Emilia Păunescu, Patrycja Nowak-Sliwinska, Arjan W. Griffioen, Rosario Scopelliti and Paul J. Dyson
J. Med. Chem., 2015, 58, 3356
DOI: 10.1021/jm501655t

Antiangiogenic and Anticancer Properties of Bifunctional Ruthenium(II)–p-Cymene Complexes: Influence of Pendant Perfluorous Chains
Patrycja Nowak-Sliwinska, Catherine M. Clavel, Emilia Păunescu, Marije T. te Winkel, Arjan W. Griffioen and Paul J. Dyson
Mol. Pharmaceutics, 2015, 12, 3089
DOI: 10.1021/acs.molpharmaceut.5b00417

Facile synthesis of [Ru(η2-O2CO)(pta)(η6-p-cymene)], an outstandingly active Ru(II) half-sandwich complex for redox isomerization of allylic alcohols
Evelin Bolyog-Nagy, Antal Udvardy, Ágnes Barczáné-Bertók, Ferenc Joó and Ágnes Kathó
Inorganica Chimica Acta, 2017, 455, 514
DOI: 10.1016/j.ica.2016.06.041

Synthesis, spectral and structural studies of water soluble arene ruthenium (II) complexes containing 2,2′-dipyridyl-N-alkylimine ligand
Keisham Sarjit Singh and Werner Kaminsky
Inorganica Chimica Acta, 2011, 365, 487
DOI: 10.1016/j.ica.2010.09.037

pH-Dependent Modulation of Reactivity in Ruthenium(II) Organometallics
Timothy J. Prior, Huguette Savoie, Ross W. Boyle and Benjamin S. Murray
Organometallics, 2018, 37, 294
DOI: 10.1021/acs.organomet.7b00868

RuII and RuIII complexes with 2,6-di-tert-butylphenol ligands: synthesis, electrochemical behaviour, antioxidant properties and antiproliferative activity
Anastasia A. Antonets, Ksenia M. Voroshilkina, Ilya A. Shutkov, Dmitrii M. Mazur, Vladimir Yu. Tyurin, Ludmila G. Dubova, Elena F. Shevtsova, Alexey A. Nazarov and Elena R. Milaeva
Mendeleev Communications, 2024, 34, 74
DOI: 10.1016/j.mencom.2024.01.022

Cytotoxic half-sandwich rhodium(III) complexes: Polypyridyl ligand influence on their DNA binding properties and cellular uptake
Michael A. Scharwitz, Ingo Ott, Yvonne Geldmacher, Ronald Gust and William S. Sheldrick
Journal of Organometallic Chemistry, 2008, 693, 2299
DOI: 10.1016/j.jorganchem.2008.04.002

Synthesis, structure and anticancer activity of (η6-benzene) ruthenium(II) complexes containing aroylhydrazone ligands
Nanjan Mohan, Subramanian Muthumari and Rengan Ramesh
Journal of Organometallic Chemistry, 2016, 807, 45
DOI: 10.1016/j.jorganchem.2016.01.033

Synthesis and In Vitro (Anticancer) Evaluation of η6-Arene Ruthenium Complexes Bearing Stannyl Ligands
Olivier Renier, Connor Deacon-Price, Joannes Peters, Kunsulu Nurekeyeva, Catherine Russon, Simba Dyson, Siyabonga Ngubane, Judith Baumgartner, Paul Dyson, Tina Riedel, Haleden Chiririwa and Burgert Blom
Inorganics, 2017, 5, 44
DOI: 10.3390/inorganics5030044

Synthesis and reactivity of rhodium(III) pentamethylcyclopentadienyl complexes of N–B–PTA(BH3): X-ray crystal structures of [Cp∗RhCl2{N–B}–PTA(BH3)] and [Cp∗Rh{N–B–PTA(BH3)}(η2-CH2=CHPh)]
Sandra Bolaño, Alberto Albinati, Jorge Bravo, Maria Caporali, Luca Gonsalvi, Louise Male, M.a Mar Rodríguez-Rocha, Andrea Rossin and Maurizio Peruzzini
Journal of Organometallic Chemistry, 2008, 693, 2397
DOI: 10.1016/j.jorganchem.2008.04.006

CZE–ICP-MS as a tool for studying the hydrolysis of ruthenium anticancer drug candidates and their reactivity towards the DNA model compound dGMP
Michael Groessl, Christian G. Hartinger, Paul J. Dyson and Bernhard K. Keppler
Journal of Inorganic Biochemistry, 2008, 102, 1060
DOI: 10.1016/j.jinorgbio.2007.11.018

Binding of Organometallic Ruthenium(II) and Osmium(II) Complexes to an Oligonucleotide:  A Combined Mass Spectrometric and Theoretical Study
Antoine Dorcier, Paul J. Dyson, Christian Gossens, Ursula Rothlisberger, Rosario Scopelliti and Ivano Tavernelli
Organometallics, 2005, 24, 2114
DOI: 10.1021/om049022a

DNA Structural Distortions Induced by Ruthenium−Arene Anticancer Compounds
Christian Gossens, Ivano Tavernelli and Ursula Rothlisberger
J. Am. Chem. Soc., 2008, 130, 10921
DOI: 10.1021/ja800194a

Use of Chelating Ligands to Tune the Reactive Site of Half‐Sandwich Ruthenium(II)–Arene Anticancer Complexes
Rafael Fernández, Michael Melchart, Abraha Habtemariam, Simon Parsons and Peter J. Sadler
Chemistry A European J, 2004, 10, 5173
DOI: 10.1002/chem.200400640

Discovery of a Highly Tumor-Selective Organometallic Ruthenium(II)–Arene Complex
Catherine M. Clavel, Emilia Păunescu, Patrycja Nowak-Sliwinska, Arjan W. Griffioen, Rosario Scopelliti and Paul J. Dyson
J. Med. Chem., 2014, 57, 3546
DOI: 10.1021/jm5002748

Chemistry by Nanocatalysis: First Example of a Solid‐Supported RAPTA Complex for Organic Reactions in Aqueous Medium
Sergio E. García‐Garrido, Javier Francos, Victorio Cadierno, Jean‐Marie Basset and Vivek Polshettiwar
ChemSusChem, 2011, 4, 104
DOI: 10.1002/cssc.201000280

Syntheses, crystal structures, susceptibility and EPR studies of oxo-bridged dinuclear ruthenium (III) complexes with linear Ru–O–Ru bonds: and [(Py)3(C2O4)RuIIIORuIII(C2O4)(Py)3] and [(4-MePy)3(C2O4)RuIIIORuIII(C2O4)(4-MePy)3]·2-Mebmz ·3H2O (Py=pyridine; 4-MePy=4-methylpyridine; 2-Mebmz=2-methylbenzimidazole)
Wen-Zhen Wang, Xin Liu, Dai-Zheng Liao, Zong-Hui Jiang, Shi-Ping Yan and Geng-Lin Wang
Inorganic Chemistry Communications, 2002, 5, 1007
DOI: 10.1016/S1387-7003(02)00622-6

pH effects on optical and DNA binding properties of a thiophene-containing ruthenium(II) complex
Zhen-Sheng Li, Huai-Xia Yang, An-Guo Zhang, Hong Luo and Ke-Zhi Wang
Inorganica Chimica Acta, 2011, 370, 132
DOI: 10.1016/j.ica.2011.01.039

Discovery and Investigation of Anticancer Ruthenium–Arene Schiff-Base Complexes via Water-Promoted Combinatorial Three-Component Assembly
Mun Juinn Chow, Cynthia Licona, Daniel Yuan Qiang Wong, Giorgia Pastorin, Christian Gaiddon and Wee Han Ang
J. Med. Chem., 2014, 57, 6043
DOI: 10.1021/jm500455p

Binuclear half-sandwich ruthenium(II) Schiff base complexes: Synthesis, characterization, DFT study and catalytic activity for the reduction of nitroarenes
Raja Nandhini, Bellie Sundaram Krishnamoorthy and Galmari Venkatachalam
Journal of Organometallic Chemistry, 2019, 903, 120984
DOI: 10.1016/j.jorganchem.2019.120984

Metal-Based Inhibition of Poly(ADP-ribose) Polymerase − The Guardian Angel of DNA
Filipa Mendes, Michael Groessl, Alexey A. Nazarov, Yury O. Tsybin, Gianni Sava, Isabel Santos, Paul J. Dyson and Angela Casini
J. Med. Chem., 2011, 54, 2196
DOI: 10.1021/jm2000135

Cyclic tetranuclear half-sandwich ruthenium(II) complexes with 4,7-phenanthroline and hydroxo bridges: Crystal structure, solution behaviour and binding to nucleosides
Miguel A. Galindo, Miguel Quirós, M. Angustias Romero and Jorge A.R. Navarro
Journal of Inorganic Biochemistry, 2008, 102, 1025
DOI: 10.1016/j.jinorgbio.2007.11.009

Towards Light‐Activated Ruthenium–Arene (RAPTA‐Type) Prodrug Candidates
Anna K. Renfrew, Johannes Karges, Rosario Scopelliti, Felix D. Bobbink, Patrycja Nowak‐Sliwinska, Gilles Gasser and Paul J. Dyson
ChemBioChem, 2019, 20, 2876
DOI: 10.1002/cbic.201900236

Synthesis and the Effect of a Peripheral N‐Arylcarbazole Moiety on theAcid‐Base and DNA Binding Properties of a Novel RuII Complex
Yuan‐Yuan Lü, Li‐Hua Gao, Mei‐Jiao Han and Ke‐Zhi Wang
Eur J Inorg Chem, 2006, 2006, 430
DOI: 10.1002/ejic.200500748

Reactions of a cytotoxic hexanuclear arene ruthenium assembly with biological ligands
Lydia E.H. Paul, Julien Furrer and Bruno Therrien
Journal of Organometallic Chemistry, 2013, 734, 45
DOI: 10.1016/j.jorganchem.2012.12.011

How half sandwich ruthenium compounds interact with DNA while not being hydrolyzed; a comparative study
Theodoros Tsolis, Konstantinos D. Papavasileiou, Spyridon A. Divanis, Vasilios S. Melissas and Achilleas Garoufis
Journal of Inorganic Biochemistry, 2016, 160, 12
DOI: 10.1016/j.jinorgbio.2016.04.008

Analysis of organometallic compounds using ion trap mass spectrometry
Paul J Dyson and J.Scott McIndoe
Inorganica Chimica Acta, 2003, 354, 68
DOI: 10.1016/S0020-1693(03)00369-4

Efficient Oxidation of Cysteine and Glutathione Catalyzed by a Dinuclear Areneruthenium Trithiolato Anticancer Complex
Federico Giannini, Georg Süss-Fink and Julien Furrer
Inorg. Chem., 2011, 50, 10552
DOI: 10.1021/ic201941j

Biological activity and cellular uptake of [Ru(η5-C5H5)(PPh3)(Me2bpy)][CF3SO3] complex
Tânia S. Morais, Filipa Santos, Leonor Côrte-Real, Fernanda Marques, M. Paula Robalo, Paulo J. Amorim Madeira and M. Helena Garcia
Journal of Inorganic Biochemistry, 2013, 122, 8
DOI: 10.1016/j.jinorgbio.2013.01.011

Designing Ruthenium Anticancer Drugs: What Have We Learnt from the Key Drug Candidates?
James P. C. Coverdale, Thaisa Laroiya-McCarron and Isolda Romero-Canelón
Inorganics, 2019, 7, 31
DOI: 10.3390/inorganics7030031

Reaction of [(C6H6)RuCl2]2 with 7,8-benzoquinoline and 8-hydroxyquinoline
J.G. Małecki, M. Jaworska, R. Kruszynski and J. Kłak
Polyhedron, 2005, 24, 3012
DOI: 10.1016/j.poly.2005.06.053

Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents
Mousumi Pal, Utpal Nandi and Debaraj Mukherjee
European Journal of Medicinal Chemistry, 2018, 150, 419
DOI: 10.1016/j.ejmech.2018.03.015

Covalent versus Noncovalent Binding of Ruthenium η6‐p‐Cymene Complexes to Zinc‐Finger Protein NCp7
Yaping Sheng, Zhuanghao Hou, Shiyong Cui, Kaiming Cao, Siming Yuan, Mei Sun, Jakob Kljun, Guangming Huang, Iztok Turel and Yangzhong Liu
Chemistry A European J, 2019, 25, 12789
DOI: 10.1002/chem.201902434

Synthesis and cellular impact of diene–ruthenium(II) complexes: A new class of organoruthenium anticancer agents
Christine Kasper, Hamed Alborzinia, Suzan Can, Igor Kitanovic, Andreas Meyer, Yvonne Geldmacher, Melanie Oleszak, Ingo Ott, Stefan Wölfl and William S. Sheldrick
Journal of Inorganic Biochemistry, 2012, 106, 126
DOI: 10.1016/j.jinorgbio.2011.08.027

A Ruthenium Antimetastasis Agent Forms Specific Histone Protein Adducts in the Nucleosome Core
Bin Wu, Michelle S. Ong, Michael Groessl, Zenita Adhireksan, Christian G. Hartinger, Paul J. Dyson and Curt A. Davey
Chemistry A European J, 2011, 17, 3562
DOI: 10.1002/chem.201100298

Medicinal Utility of Some Schiff Bases and their Complexes with First Transition Series Metals: A Review
Tahmeena Khan, Saima Zehra, Almas Alvi, Umama Fatima and Alfred J. Lawrence
Orient. J. Chem, 2021, 37, 1051
DOI: 10.13005/ojc/370506

Ruthenium(II) Complexes of Thiosemicarbazones: The First Water‐Soluble Complex with pH‐Dependent Antiproliferative Activity
Sanja Grguric‐Sipka, Christian R. Kowol, Seied‐Mojtaba Valiahdi, Rene Eichinger, Michael A. Jakupec, Alexander Roller, Sergiu Shova, Vladimir B. Arion and Bernhard K. Keppler
Eur J Inorg Chem, 2007, 2007, 2870
DOI: 10.1002/ejic.200601196

Hemilabile β-Aminophosphine Ligands Derived from 1,3,5-Triaza-7-phosphaadamantane: Application in Aqueous Ruthenium Catalyzed Nitrile Hydration
Wei-Chih Lee, Jeremiah M. Sears, Raphel A. Enow, Kelly Eads, Donald A. Krogstad and Brian J. Frost
Inorg. Chem., 2013, 52, 1737
DOI: 10.1021/ic301160x

Study of reactivity ofp-cymene ruthenium(II) dimer towards diphenyl-2-pyridylphosphine: Synthesis, characterization and molecular structures of [(η6-p-cymene)RuCl2(PPh2Py)] and [(η6-p-cymene)RuCl(PPh2Py)]BF4
R. Lalrempuia, Patrick J. Carroll and Mohan Rao Kollipara
J Chem Sci, 2004, 116, 21
DOI: 10.1007/BF02708209

Exploring Metal Complexes for Cancer Treatment: Mechanistic Insights and Therapeutic Potential
Pandey Priya Arun, Ritu Raj Patel, Sudhir Kumar Singh, Kailash Parmar and Meenakshi Singh
Journal of Organometallic Chemistry, 2025, 1035, 123682
DOI: 10.1016/j.jorganchem.2025.123682

Transcription Inhibition by Organometallic Ruthenium - Arene Anticancer Complexes in Live Mammalian Cells
Astrid Astarina, Mun Juinn Chow and Wee Han Ang
Aust. J. Chem., 2012, 65, 1271
DOI: 10.1071/CH12059

Harmless glucose‐modified ruthenium complexes suppressing cell migration of highly invasive cancer cell lines
Martin Lamač, Michal Horáček, Lucie Červenková Šťastná, Jindřich Karban, Lucia Sommerová, Hana Skoupilová, Roman Hrstka and Jiří Pinkas
Applied Organom Chemis, 2020, 34
DOI: 10.1002/aoc.5318

Unravelling the Relaxation Pathway and Excited State Dynamics of Ruthenium(II) Polypyridyl Complexes Incorporating Phosphorus‐Based Monodentate Ligands
Ramranjan Mishra, Abhijit Saha, Pritha Chatterjee, Sucheta Kundu, Madhu Verma, Sabyasachi Sarkar, Sri Sivakumar, Anindya Datta and Ashis K. Patra
Chemistry A European J, 2025, 31
DOI: 10.1002/chem.202404231

Bilosomal Encapsulation of Binuclear Phosphino Ru(II)–Cu(II) Compounds Enhances Their Selectivity and Activity toward Lung and Prostate Cancers
Sandra Kozieł, Daria Wojtala, Agata Barzowska-Gogola, Barbara Pucelik, Ewelina Waglewska, Miłosz Siczek, Maciej Witwicki, Alessandro Niorettini, Agnieszka Kyzioł, Magdalena Malik, Urszula Bazylińska, Ewa Błaszczak and Urszula K. Komarnicka
J. Med. Chem., 2025, 68, 14442
DOI: 10.1021/acs.jmedchem.5c00486

Studies on the reactivity of organometallic Ru–, Rh– and Os–pta complexes with DNA model compounds
Antoine Dorcier, Christian G. Hartinger, Rosario Scopelliti, Richard H. Fish, Bernhard K. Keppler and Paul J. Dyson
Journal of Inorganic Biochemistry, 2008, 102, 1066
DOI: 10.1016/j.jinorgbio.2007.10.016

Structural Determination of Ruthenium Complexes Containing Bi-Dentate Pyrrole-Ketone Ligands
Ya-Wen Tsai, Yun-Fan Chen, Yong-Jie Li, Kuan-Hung Chen, Chia-Her Lin and Jui-Hsien Huang
Molecules, 2018, 23, 159
DOI: 10.3390/molecules23010159

Heteronuclear dual-metal atom catalysts for nanocatalytic tumor therapy
Jingyi Han and Jingqi Guan
Chinese Journal of Catalysis, 2023, 47, 1
DOI: 10.1016/S1872-2067(22)64207-4

In Vitro Anticancer Activity and Biologically Relevant Metabolization of Organometallic Ruthenium Complexes with Carbohydrate‐Based Ligands
Isabella Berger, Muhammad Hanif, Alexey A. Nazarov, Christian G. Hartinger, Roland O. John, Maxim L. Kuznetsov, Michael Groessl, Frederic Schmitt, Olivier Zava, Florian Biba, Vladimir B. Arion, Mathea Sophia Galanski, Michael A. Jakupec, Lucienne Juillerat‐Jeanneret, Paul J. Dyson and Bernhard K. Keppler
Chemistry A European J, 2008, 14, 9046
DOI: 10.1002/chem.200801032

Recent development of transition metal complexes with in vivo antitumor activity
Jia-Xin Liang, Hai-Jing Zhong, Guanjun Yang, Kasipandi Vellaisamy, Dik-Lung Ma and Chung-Hang Leung
Journal of Inorganic Biochemistry, 2017, 177, 276
DOI: 10.1016/j.jinorgbio.2017.06.002

Ruthenium(II) piano stool coordination compounds with aminomethylphosphanes: Synthesis, characterisation and preliminary biological study in vitro
Michał Płotek, Radosław Starosta, Urszula K. Komarnicka, Agnieszka Skórska-Stania, Przemysław Kołoczek and Agnieszka Kyzioł
Journal of Inorganic Biochemistry, 2017, 170, 178
DOI: 10.1016/j.jinorgbio.2017.02.017

Synthesis, Characterisation, and in vitro Cytotoxic Activity of Dithiocarbamato Glycoconjugate Half‐Sandwich Ruthenium and Osmium Complexes
Joan J. Soldevila‐Barreda, Andrea Pettenuzzo, Maria Azmanova, Laia Rafols, Amr A. A. Attia, Alexandru Lupan, Luca Ronconi, Nicolas P. E. Barry and Anaïs Pitto‐Barry
Helvetica Chimica Acta, 2023, 106
DOI: 10.1002/hlca.202300064

Naphthalene Diimide-Functionalized Half-Sandwich Ru(II) Complexes as Mitochondria-Targeted Anticancer and Antimetastatic Agents
Yuliang Yang, Xiaofeng Zou, Yanyan Sun, Feihong Chen, Jian Zhao and Shaohua Gou
Inorg. Chem., 2023, 62, 9649
DOI: 10.1021/acs.inorgchem.3c01125

Synthesis, structure, electrochemistry and cytotoxicity studies of Ru(II) and Pt(II)–N-heterocyclic carbene complexes of CNC-pincer ligand
Joydev Dinda, Sirsendu Das Adhikary, Gourisankar Roymahapatra, Kiran K. Nakka and Manas Kumar Santra
Inorganica Chimica Acta, 2014, 413, 23
DOI: 10.1016/j.ica.2013.12.022

In vitro Ruthenation of Human Breast Cancer Suppressor Gene 1 (BRCA1) by the Antimetastasis Compound RAPTA‐C and Its Analogue CarboRAPTA‐C
Adisorn Ratanaphan, Pornvichai Temboot and Paul J. Dyson
Chemistry & Biodiversity, 2010, 7, 1290
DOI: 10.1002/cbdv.200900288

Conjugation of a Ru(II) Arene Complex to Neomycin or to Guanidinoneomycin Leads to Compounds with Differential Cytotoxicities and Accumulation between Cancer and Normal Cells
Ariadna Grau-Campistany, Anna Massaguer, Dolors Carrion-Salip, Flavia Barragán, Gerard Artigas, Paula López-Senín, Virtudes Moreno and Vicente Marchán
Mol. Pharmaceutics, 2013, 10, 1964
DOI: 10.1021/mp300723b

Chlorido(η6-N2-diphenylphosphanyl-N1,N1-diisopropyl-4-methoxybenzamidine-κP)(triphenylphosphane-κP)ruthenium(II) trifluoromethansulfonate acetone disolvate
Manel Kéchaou-Perrot, Laure Vendier and Alain Igau
Acta Crystallogr E Struct Rep Online, 2013, 69, m659
DOI: 10.1107/S1600536813029450

Facile entry to germanate and stannate complexes [(η6-arene)RuCl(η2-dppm)]+[ECl3]- (E = Ge, Sn) as potent anti-cancer agents
Niccolo Aldeghi, Dario Romano, Christoph Marschner, Supratim Biswas, Suparna Chakraborty, Sharon Prince, Siyabonga Ngubane and Burgert Blom
Journal of Organometallic Chemistry, 2020, 916, 121214
DOI: 10.1016/j.jorganchem.2020.121214

Ruthenium(II)–Arene Complexes with Glycosylated NHC-Carbene Co-Ligands: Synthesis, Hydrolytic Behavior, and Binding to Biological Molecules
Alfonso Annunziata, Maria Elena Cucciolito, Maddalena Di Ronza, Giarita Ferraro, Mouna Hadiji, Antonello Merlino, Daniel Ortiz, Rosario Scopelliti, Farzaneh Fadaei Tirani, Paul J. Dyson and Francesco Ruffo
Organometallics, 2023, 42, 952
DOI: 10.1021/acs.organomet.3c00128

Multinuclear biologically active Ru, Rh, Os and Ir arene complexes
Pavel Štarha
Coordination Chemistry Reviews, 2021, 431, 213690
DOI: 10.1016/j.ccr.2020.213690

Photophysical and Biological Studies with Organometallic Ruthenium Complexes of Selenodiazole Ligands
Raja Mitra, V. S. Sridevi, Kumaravel Somasundaram and Ashoka G. Samuelson
Proc. Natl. Acad. Sci., India, Sect. A Phys. Sci., 2016, 86, 511
DOI: 10.1007/s40010-016-0292-y

Binding of Organometallic Ruthenium(II) Anticancer Compounds to Nucleobases: A Computational Study
Christian Gossens, Ivano Tavernelli and Ursula Rothlisberger
J. Phys. Chem. A, 2009, 113, 11888
DOI: 10.1021/jp903237w

DNA groove-binding and acid-base properties of a Ru(II) complex containing anthryl moieties
Hong-Ju Yin, An-Guo Zhang, Li-Hua Gao, Hua Zhao and Ke-Zhi Wang
Nucleosides, Nucleotides & Nucleic Acids, 2020, 39, 592
DOI: 10.1080/15257770.2019.1669804

Half-sandwich d 6 metal complexes comprising of 2-substituted-1,8-napthyridine ligands with unexpected bonding modes: Synthesis, structural and anti-cancer studies
Sanjay Adhikari, Omar Hussain, Roger M. Phillips and Mohan Rao Kollipara
Journal of Organometallic Chemistry, 2018, 854, 27
DOI: 10.1016/j.jorganchem.2017.11.011

Analysis of ruthenium anticancer agents by MEEKC‐UV and MEEKC–ICP‐MS: Impact of structural motifs on lipophilicity and biological activity
Kai Giringer, Hannah U. Holtkamp, Sanam Movassaghi, William D. J. Tremlett, Nelson Y. S. Lam, Mario Kubanik and Christian G. Hartinger
Electrophoresis, 2018, 39, 1201
DOI: 10.1002/elps.201700443

Synthesis and antimicrobial studies of half-sandwich arene platinum group complexes containing pyridylpyrazolyl ligands
Ibaniewkor Lyngdoh Mawnai, Sanjay Adhikari, Lincoln Dkhar, Jaya Lakshmi Tyagi, Krishna Mohan Poluri and Mohan Rao Kollipara
Journal of Coordination Chemistry, 2019, 72, 294
DOI: 10.1080/00958972.2018.1556791

Current and future potential of metallo drugs: Revisiting DNA-binding of metal containing molecules and their diverse mechanism of action
Mehvash Zaki, Farukh Arjmand and Sartaj Tabassum
Inorganica Chimica Acta, 2016, 444, 1
DOI: 10.1016/j.ica.2016.01.006

Incorporating ruthenium into advanced drug delivery carriers – an innovative generation of chemotherapeutics
Bianca M. Blunden and Martina H. Stenzel
J of Chemical Tech & Biotech, 2015, 90, 1177
DOI: 10.1002/jctb.4507

Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Reece G. Kenny and Celine J. Marmion
Chem. Rev., 2019, 119, 1058
DOI: 10.1021/acs.chemrev.8b00271

Metabolization of [Ru(η6-C6H5CF3)(pta)Cl2]: a cytotoxic RAPTA-type complex with a strongly electron withdrawing arene ligand
Alexander E. Egger, Christian G. Hartinger, Anna K. Renfrew and Paul J. Dyson
J Biol Inorg Chem, 2010, 15, 919
DOI: 10.1007/s00775-010-0654-x

Organometallic Ruthenium Inhibitors of Glutathione‐S‐Transferase P1‐1 as Anticancer Drugs
Wee Han Ang, Anastasia De Luca, Catherine Chapuis‐Bernasconi, Lucienne Juillerat‐Jeanneret, Mario Lo Bello and Paul J. Dyson
ChemMedChem, 2007, 2, 1799
DOI: 10.1002/cmdc.200700209

Catalytic activity assessment of [RuCl2 (p-cymene) (PTA)] in the synthesis of enol esters
Eric Musengimana and Claver Fatakanwa
J IRAN CHEM SOC, 2016, 13, 253
DOI: 10.1007/s13738-015-0732-7

Anticancer Ru and Os complexes of N-(4-chlorophenyl)pyridine-2-carbothioamide: Substitution of the labile chlorido ligand with phosphines
Zahid Riaz, Betty Y.T. Lee, Julia Stjärnhage, Sanam Movassaghi, Tilo Söhnel, Stephen M.F. Jamieson, Muhammad Ashraf Shaheen, Muhammad Hanif and Christian G. Hartinger
Journal of Inorganic Biochemistry, 2023, 241, 112115
DOI: 10.1016/j.jinorgbio.2022.112115

Tuning the anticancer activity of maltol-derived ruthenium complexes by derivatization of the 3-hydroxy-4-pyrone moiety
Wolfgang Kandioller, Christian G. Hartinger, Alexey A. Nazarov, Johanna Kasser, Roland John, Michael A. Jakupec, Vladimir B. Arion, Paul J. Dyson and Bernhard K. Keppler
Journal of Organometallic Chemistry, 2009, 694, 922
DOI: 10.1016/j.jorganchem.2008.10.016

Ruthenium Porphyrin Compounds for Photodynamic Therapy of Cancer
Frédéric Schmitt, Padavattan Govindaswamy, Georg Süss-Fink, Wee Han Ang, Paul J. Dyson, Lucienne Juillerat-Jeanneret and Bruno Therrien
J. Med. Chem., 2008, 51, 1811
DOI: 10.1021/jm701382p

A β-d-Allopyranoside-Grafted Ru(II) Complex: Synthesis and Acid−Base and DNA-Binding Properties
Yan-Zi Ma, Hong-Ju Yin and Ke-Zhi Wang
J. Phys. Chem. B, 2009, 113, 11039
DOI: 10.1021/jp9034503

The potential of organometallic complexes in medicinal chemistry
Gilles Gasser and Nils Metzler-Nolte
Current Opinion in Chemical Biology, 2012, 16, 84
DOI: 10.1016/j.cbpa.2012.01.013

In vivo testing of the anti-inflammatory action of topical formulations containing cobalt complexes with oxicams
George T. A. Burcea-Dragomiroiu, Elena Moroșan, Daniela-Elena Popa, Sultana Niţă, Iuksel Rasit, Minerva Panteli, Kirill S. Golokhvast and Octav Ginghină
Public Health Toxicol, 2023, 3, 1
DOI: 10.18332/pht/159112

Modifying the structure of dinuclear ruthenium complexes with antitumor activity
Maria G. Mendoza‐Ferri, Christian G. Hartinger, Alexey A. Nazarov, Wolfgang Kandioller, Kay Severin and Bernhard K. Keppler
Applied Organom Chemis, 2008, 22, 326
DOI: 10.1002/aoc.1394

Mass spectrometry and metallomics: A general protocol to assess stability of metallodrug-protein adducts in bottom-up MS experiments
Elena Michelucci, Giuseppe Pieraccini, Gloriano Moneti, Chiara Gabbiani, Alessandro Pratesi and Luigi Messori
Talanta, 2017, 167, 30
DOI: 10.1016/j.talanta.2017.01.074

Synthesis, structure and anti-cancer activity of osmium complexes bearing π-bound arene substituents and phosphane Co-Ligands: A review
Tomiris Nabiyeva, Christoph Marschner and Burgert Blom
European Journal of Medicinal Chemistry, 2020, 201, 112483
DOI: 10.1016/j.ejmech.2020.112483

Multifaceted Chemistry of [(Cymene)RuCl2]2and PCy3
Euro Solari, Sébastien Gauthier, Rosario Scopelliti and Kay Severin
Organometallics, 2009, 28, 4519
DOI: 10.1021/om900374e

Stability of an organometallic ruthenium–ubiquitin adduct in the presence of glutathione: Relevance to antitumour activity
Christian G. Hartinger, Angela Casini, Céline Duhot, Yury O. Tsybin, Luigi Messori and Paul J. Dyson
Journal of Inorganic Biochemistry, 2008, 102, 2136
DOI: 10.1016/j.jinorgbio.2008.08.002

Use of Perfluorinated Phosphines to Provide Thermomorphic Anticancer Complexes for Heat-Based Tumor Targeting
Anna K. Renfrew, Rosario Scopelliti and Paul J. Dyson
Inorg. Chem., 2010, 49, 2239
DOI: 10.1021/ic9020433

Between Adamantane and Atrane: Intrabridgehead Interactions in the Cage‐Like Phosphane Related to a Novel Tris(homoadamantane) Ring System
Sergey N. Britvin, Andrey M. Rumyantsev, Anastasia E. Zobnina and Marina V. Padkina
Chemistry A European J, 2016, 22, 14227
DOI: 10.1002/chem.201601637

Influence of the Diketonato Ligand on the Cytotoxicities of [Ru(η6‐p‐cymene)(R2acac)(PTA)]+ Complexes (PTA = 1,3,5‐triaza‐7‐phosphaadamantane)
Carsten A. Vock, Anna K. Renfrew, Rosario Scopelliti, Lucienne Juillerat‐Jeanneret and Paul J. Dyson
Eur J Inorg Chem, 2008, 2008, 1661
DOI: 10.1002/ejic.200701291

Cationic fluorine-containing amphiphilic graft copolymers as DNA carriers
Sheng-Dong Xiong, Ling Li, Jiang Jiang, Li-Ping Tong, Shuilin Wu, Zu-Shun Xu and Paul K. Chu
Biomaterials, 2010, 31, 2673
DOI: 10.1016/j.biomaterials.2009.12.014

A QM/MM study of the binding of RAPTA ligands to cathepsin B
Antonella Ciancetta, Samuel Genheden and Ulf Ryde
J Comput Aided Mol Des, 2011, 25, 729
DOI: 10.1007/s10822-011-9448-7

Synthesis, X-ray crystal structure and cytotoxicity of a new tetranuclear ruthenium arene complex
Anna Louisa Noffke, Melanie Bongartz, Wim Wätjen, Philip Böhler, Bernhard Spingler and Peter C. Kunz
Journal of Organometallic Chemistry, 2011, 696, 1096
DOI: 10.1016/j.jorganchem.2010.10.042

Multi-analytical studies about physico-chemical properties of Ni(II)-vitamin B6 coordination compounds and their CT-DNA interactions
Agnieszka Chylewska, Małgorzata Biedulska and Mariusz Makowski
Journal of Molecular Liquids, 2017, 243, 771
DOI: 10.1016/j.molliq.2017.08.100

Synthesis and Structure of an Unusual Carbonyl Ruthenium(II) Complex Containing Neutral NO2 as Ligand: [Ru(NO2)4(CO)(H2O)]Cl2·2H2O
Wen‐Zhen Wang, Xin Liu, Dai‐Zheng Liao, Zong‐Hui Jiang, Shi‐Ping Yan and Geng‐Lin Wang
Zeitschrift anorg allge chemie, 2003, 629, 1585
DOI: 10.1002/zaac.200300147

New Tailored RNA-Targeted Organometallic Drug Candidates against Huh7 (Liver) and Du145 (Prostate) Cancer Cell Lines
Huzaifa Yasir Khan, Santosh K. Maurya, Hifzur R. Siddique, Shariq Yousuf and Farukh Arjmand
ACS Omega, 2020, 5, 15218
DOI: 10.1021/acsomega.0c01206

Developing the Kharasch Reaction in Aqueous Media: Dinuclear Group 8 and 9 Catalysts Containing the Bridging Cage Ligand Tris(1,2‐dimethylhydrazino)diphosphane
Alba E. Díaz‐Álvarez, Pascale Crochet, Maria Zablocka, Carine Duhayon, Victorio Cadierno and Jean‐Pierre Majoral
Eur J Inorg Chem, 2008, 2008, 786
DOI: 10.1002/ejic.200701132

Protein binding affinity of biologically active thiourea based half-sandwich Ru(II) cymene complexes
Ahmed M. Mansour and Krzysztof Radacki
Polyhedron, 2020, 175, 114175
DOI: 10.1016/j.poly.2019.114175

Synthesis, Structural, and Quantum Chemical Analysis of Neutral and Cationic Ruthenium(II) Complexes with Nicotinate-Polyethylene Glycol Ester Ligands
Dušan Dimić, Thomas Eichhorn, Dejan Milenković and Goran N. Kaluđerović
Inorganics, 2023, 11, 460
DOI: 10.3390/inorganics11120460

Thiolato-bridged dinuclear arene ruthenium complexes and their potential as anticancer drugs
Julien Furrer and Georg Süss-Fink
Coordination Chemistry Reviews, 2016, 309, 36
DOI: 10.1016/j.ccr.2015.10.007

The Significant Influence of a Second Metal on the Antiproliferative Properties of the Complex [Ru(η6−C10H14)(Cl2)(dmoPTA)]
Nazanin Kordestani, Elisa Abas, Laura Grasa, Andres Alguacil, Franco Scalambra and Antonio Romerosa
Chemistry A European J, 2022, 28
DOI: 10.1002/chem.202103048

Redox‐Induced Binding of [(tacn)ReIIBr(CO)2]+ to Guanine, Oligonucleotides, and Peptides
Fabio Zobi and Roger Alberto
Chemistry A European J, 2010, 16, 2710
DOI: 10.1002/chem.200902760

Characterizing activation mechanisms and binding preferences of ruthenium metallo-prodrugs by a competitive binding assay
Christian Artner, Hannah U. Holtkamp, Christian G. Hartinger and Samuel M. Meier-Menches
Journal of Inorganic Biochemistry, 2017, 177, 322
DOI: 10.1016/j.jinorgbio.2017.07.010

Design and Synthesis of Nitrogen‐Rich Triazole‐Based Mononuclear Ru(II) Arene Complexes Toward Anticancer Activities
Anushka Verma, Arabinda Muley, Vuppaladadium Shanmuga Sharan Rathnam, Jitender Jangra, Shobhit Mathur, Roy Anindya and Somnath Maji
Eur J Inorg Chem, 2025
DOI: 10.1002/ejic.202500300

Intramolecular Hydrogen-Bonded Tertiary Phosphines as 1,3,5-Triaza-7-phosphaadamantane (PTA) Analogues
Allen T. Ekubo, Mark R. J. Elsegood, Andrew J. Lake and Martin B. Smith
Inorg. Chem., 2009, 48, 2633
DOI: 10.1021/ic801709z

Imidazole/4,4′-azopyridine bridging binuclear Ru(II) complexes: design, synthesis, bimolecular interactions and cytotoxicity against HeLa cell line
Priyanka Khanvilkar, Soumya R. Dash, Ramadevi Pulipaka, Kavita Shirsath, Ranjitsinh Devkar and Debjani Chakraborty
J IRAN CHEM SOC, 2021, 18, 3313
DOI: 10.1007/s13738-021-02271-3

Water-soluble (η6-arene)ruthenium(II)-phosphine complexes and their catalytic activity in the hydrogenation of bicarbonate in aqueous solution
Henrietta Horváth, Gábor Laurenczy and Ágnes Kathó
Journal of Organometallic Chemistry, 2004, 689, 1036
DOI: 10.1016/j.jorganchem.2003.11.036

Inhibitory activities and possible anticancer targets of Ru(II)-based complexes using computational docking method
Adebayo A. Adeniyi and Peter A. Ajibade
Journal of Molecular Graphics and Modelling, 2012, 38, 60
DOI: 10.1016/j.jmgm.2012.08.004

A split β-lactamase sensor for the detection of DNA modification by cisplatin and ruthenium-based chemotherapeutic drugs
Samuel R. Hinton, Elizabeth L.S. Corpuz, Karen L. McFarlane Holman and Scott C. Meyer
Journal of Inorganic Biochemistry, 2022, 236, 111986
DOI: 10.1016/j.jinorgbio.2022.111986

Organoruthenium Antagonists of Human A3 Adenosine Receptors
Priyankar Paira, Mun Juinn Chow, Gopalakrishnan Venkatesan, Vamsi Krishna Kosaraju, Siew Lee Cheong, Karl‐Norbert Klotz, Wee Han Ang and Giorgia Pastorin
Chemistry A European J, 2013, 19, 8321
DOI: 10.1002/chem.201203291

Ruthenium(II)–arene complexes of diimines: Effect of diimine intercalation and hydrophobicity on DNA and protein binding and cytotoxicity
Mani Ganeshpandian, Mallayan Palaniandavar, Amsaveni Muruganantham, Swapan K. Ghosh, Anvarbatcha Riyasdeen and Mohammad Abdulkader Akbarsha
Applied Organom Chemis, 2018, 32
DOI: 10.1002/aoc.4154

Mass spectrometry and UV‐VIS spectrophotometry of ruthenium(II) [RuClCp(mPTA)2](OSO2CF3)2 complex in solution
Eladia María Peña‐Méndez, Beatriz González, Pablo Lorenzo, Antonio Romerosa and Josef Havel
Rapid Comm Mass Spectrometry, 2009, 23, 3831
DOI: 10.1002/rcm.4323

DNA interactions and cytotoxic studies of cis-platin analogues of substituted 2,2′-bipyridines
Mohan N. Patel, Pradhuman A. Parmar, Deepen S. Gandhi and Anshul P. Patidar
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2012, 97, 54
DOI: 10.1016/j.saa.2012.05.043

Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands
M. Helena Garcia, Tânia S. Morais, Pedro Florindo, M. Fátima M. Piedade, Virtudes Moreno, Carlos Ciudad and Veronica Noe
Journal of Inorganic Biochemistry, 2009, 103, 354
DOI: 10.1016/j.jinorgbio.2008.11.016

Synthesis and characterization of dinuclear macrocyclic cobalt(II), copper(II) and zinc(II) complexes derived from 2,2,2′,2′-S,S[bis(bis-N,N-2-thiobenzimidazolyloxalato-1,2-ethane)]: DNA binding and cleavage studies
Farukh Arjmand and Mubashira Aziz
European Journal of Medicinal Chemistry, 2009, 44, 834
DOI: 10.1016/j.ejmech.2008.05.006

Anticancer Therapeutics That Target Selenoenzymes: Synthesis, Characterization, in vitro Cytotoxicity, and Thioredoxin Reductase Inhibition of a Series of Gold(I) Complexes Containing Hydrophilic Phosphine Ligands
Elena Vergara, Angela Casini, Francesca Sorrentino, Olivier Zava, Elena Cerrada, Maria Pia Rigobello, Alberto Bindoli, Mariano Laguna and Paul J. Dyson
ChemMedChem, 2010, 5, 96
DOI: 10.1002/cmdc.200900370

Cationic Ru(η6‐p‐cymene) Complexes of 3‐Hydroxy‐4‐pyr(id)ones – Lipophilic Triphenylphosphine as Co‐Ligand Is Key to Highly Stable and Cytotoxic Anticancer Agents
Shahida Parveen, Muhammad Hanif, Sanam Movassaghi, Matthew P. Sullivan, Mario Kubanik, Muhammad Ashraf Shaheen, Tilo Söhnel, Stephen M. F. Jamieson and Christian G. Hartinger
Eur J Inorg Chem, 2017, 2017, 1721
DOI: 10.1002/ejic.201601163

Dichloro Ru(II)-p-cymene-1,3,5-triaza-7-phosphaadamantane (RAPTA-C): A Case Study
Srividya Swaminathan and Ramasamy Karvembu
ACS Pharmacol. Transl. Sci., 2023, 6, 982
DOI: 10.1021/acsptsci.3c00085

X-ray Absorption Near Edge Structure Spectroscopy to Resolve the in Vivo Chemistry of the Redox-Active Indazoliumtrans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019)
Alfred A. Hummer, Petra Heffeter, Walter Berger, Martin Filipits, David Batchelor, Gabriel E. Büchel, Michael A. Jakupec, Bernhard K. Keppler and Annette Rompel
J. Med. Chem., 2013, 56, 1182
DOI: 10.1021/jm301648f

CE in anticancer metallodrug research – an update
Christian G. Hartinger and Bernhard K. Keppler
Electrophoresis, 2007, 28, 3436
DOI: 10.1002/elps.200700114

Synthesis of water-soluble ruthenium clusters by reaction with PTA (1,3,5-triaza-7-phosphaadamantane)
Nathalie Mager, Koen Robeyns and Sophie Hermans
Journal of Organometallic Chemistry, 2015, 794, 48
DOI: 10.1016/j.jorganchem.2015.06.015

New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents
Ilya A. Shutkov, Yulia N. Okulova, Dmitrii M. Mazur, Nikolai A. Melnichuk, Denis A. Babkov, Elena V. Sokolova, Alexander A. Spasov, Elena R. Milaeva and Alexey A. Nazarov
Pharmaceutics, 2023, 15, 1366
DOI: 10.3390/pharmaceutics15051366

Ruthenium-catalyzed reduction of allylic alcohols using glycerol as solvent and hydrogen donor
Alba E. Díaz-Álvarez, Pascale Crochet and Victorio Cadierno
Catalysis Communications, 2011, 13, 91
DOI: 10.1016/j.catcom.2011.07.006

Nucleophilic substitution reactions of [(η5-Cp*)Ru(η6-C6H5CO2H)]+: Synthesis, characterization and cytotoxicity of organoruthenium ester and amide complexes
Bradley T. Loughrey, Michael L. Williams, Peter G. Parsons and Peter C. Healy
Journal of Organometallic Chemistry, 2016, 819, 1
DOI: 10.1016/j.jorganchem.2016.06.012

A Novel Ruthenium(III) and Lithium Complex: Synthesis, Crystal Structure, and Magnetic Properties
Li‐Xia Bai, Xin Liu, Wen‐Zhen Wang, Dai‐Zheng Liao and Qing‐Lun Wang
Zeitschrift anorg allge chemie, 2004, 630, 1143
DOI: 10.1002/zaac.200400063

New neutral and cationic η6-arene ruthenium complexes with phosphine and amine ligands: syntheses and molecular structures of [(η6-p-cymene)Ru(NH2CH2C6H5)Cl2], [(η6-C6Me6)Ru(PPh2Py)Cl2] and [(η6-C6Me6)Ru(PPh2Py)Cl]+
P. Govindaswamy, Yurij A. Mozharivskyj and Mohan Rao Kollipara
Polyhedron, 2004, 23, 3115
DOI: 10.1016/j.poly.2004.09.031

Inverted Piano Stools: A Molecular Recognition Motif That Enforces 1:1 Cocrystallization of Two Diastereomers in the Same Single Crystal
Henri Brunner, Matthias Weber, Manfred Zabel and Thomas Zwack
Angew Chem Int Ed, 2003, 42, 1859
DOI: 10.1002/anie.200250181

DNA interaction and cytotoxic activities of square planar platinum(II) complexes with N, S-donor ligands
Mohan N. Patel, Chintan R. Patel, Hardik N. Joshi and Khyati P. Thakor
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2014, 127, 261
DOI: 10.1016/j.saa.2014.02.053

Investigating biological systems using first principles Car–Parrinello molecular dynamics simulations
Matteo Dal Peraro, Paolo Ruggerone, Simone Raugei, Francesco Luigi Gervasio and Paolo Carloni
Current Opinion in Structural Biology, 2007, 17, 149
DOI: 10.1016/j.sbi.2007.03.018

Synthesis of [RuII(η6-p-cymene)(PPh3)(L)Cl]PF6 complexes with carbohydrate-derived phosphites, imidazole or indazole co-ligands
Muhammad Hanif, Alexey A. Nazarov and Christian G. Hartinger
Inorganica Chimica Acta, 2012, 380, 211
DOI: 10.1016/j.ica.2011.10.007

Organoruthenium and Osmium Anticancer Complexes Bearing a Maleimide Functional Group: Reactivity to Cysteine, Stability, and Cytotoxicity
Sally Moon, Muhammad Hanif, Mario Kubanik, Hannah Holtkamp, Tilo Söhnel, Stephen M. F. Jamieson and Christian G. Hartinger
ChemPlusChem, 2015, 80, 231
DOI: 10.1002/cplu.201402390

Highly water soluble trithiolato-bridged dinuclear arene ruthenium complexes
Gajendra Gupta, Patrycja Nowak-Sliwinska, Noelia Herrero, Paul J. Dyson and Bruno Therrien
Inorganica Chimica Acta, 2014, 423, 524
DOI: 10.1016/j.ica.2014.09.013

Neutral 1,3,5‐Triaza‐7‐phosphaadamantane‐Ruthenium(II) Complexes as Precursors for the Preparation of Highly Water‐Soluble Derivatives
Federica Battistin, Gabriele Balducci, Elisabetta Iengo, Nicola Demitri and Enzo Alessio
Eur J Inorg Chem, 2016, 2016, 2850
DOI: 10.1002/ejic.201600084

New Water‐Soluble Rhenium Complexes with 1,3,5‐Triaza‐7‐phosphaadamantane (PTA) – X‐ray Crystal Structures of [ReNCl2(PTA)3], [ReO2Cl(PTA)3], [ReCl3­(PTA)2(PPh3)], and [Re2N2Cl3(Et2dtc)­(PTA)4]
Andrea Marchi, Elena Marchesi, Lorenza Marvelli, Paola Bergamini, Valerio Bertolasi and Valeria Ferretti
Eur J Inorg Chem, 2008, 2008, 2670
DOI: 10.1002/ejic.200800114

Novel hydridotris(pyrazolyl)borate ruthenium(II) complexes containing the water-soluble phosphane 1,3,5-triaza-7-phosphaadamantane: Synthesis and evaluation of DNA binding properties
Almudena García-Fernández, Josefina Díez, Ángel Manteca, Jesús Sánchez, M. Pilar Gamasa and Elena Lastra
Polyhedron, 2008, 27, 1214
DOI: 10.1016/j.poly.2007.12.013

Kinetic studies on the first dihydrogen aquacomplex, [Ru(H2)(H2O)5]2+: Formation under H2 pressure and catalytic H/D isotope exchange in water
Pascal V. Grundler, Oleg V. Yazyev, Nicolas Aebischer, Lothar Helm, Gábor Laurenczy and André E. Merbach
Inorganica Chimica Acta, 2006, 359, 1795
DOI: 10.1016/j.ica.2005.06.056

Synthesis, crystal structure, DNA-binding properties, cytotoxic and antioxidation activities of several ternary copper(II) complexes with a new reduced Schiff base ligand
Lei Jia, Jie Shi, Zhi-hong Sun, Fei-fei Li, Yuan Wang, Wei-na Wu and Qin Wang
Inorganica Chimica Acta, 2012, 391, 121
DOI: 10.1016/j.ica.2012.05.014

Stable, Water‐Soluble Pta‐Based Ru–Ag Organometallic Polymers
Chaker Lidrissi, Antonio Romerosa, Mustapha Saoud, Manuel Serrano‐Ruiz, Luca Gonsalvi and Maurizio Peruzzini
Angewandte Chemie, 2005, 117, 2624
DOI: 10.1002/ange.200462790

Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pr i )2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential
Federico Giannini, Julien Furrer, Anne-Flore Ibao, Georg Süss-Fink, Bruno Therrien, Olivier Zava, Mathurin Baquie, Paul J. Dyson and Petr Štěpnička
J Biol Inorg Chem, 2012, 17, 951
DOI: 10.1007/s00775-012-0911-2

Water-Soluble Mono- and Binuclear Ru(η6-p-cymene) Complexes Containing Indole Thiosemicarbazones: Synthesis, DFT Modeling, Biomolecular Interactions, and In Vitro Anticancer Activity through Apoptosis
Jebiti Haribabu, Gopal Sabapathi, Manoharan Muthu Tamizh, Chandrasekar Balachandran, Nattamai S. P. Bhuvanesh, Ponnambalam Venuvanalingam and Ramasamy Karvembu
Organometallics, 2018, 37, 1242
DOI: 10.1021/acs.organomet.8b00004

Arene–ruthenium complexes with ferrocene-derived ligands: Synthesis and characterization of complexes of the type [Ru(η6-arene)(NC5H4CH2NHOC-C5H4FeC5H5)Cl2] and [Ru(η6-arene)(NC3H3N(CH2)2O2C–C5H4FeC5H5)Cl2]
Mathieu Auzias, Joël Gueniat, Bruno Therrien, Georg Süss-Fink, Anna K. Renfrew and Paul J. Dyson
Journal of Organometallic Chemistry, 2009, 694, 855
DOI: 10.1016/j.jorganchem.2008.08.012

Ruthenium(II) arene complexes with oligocationic triarylphosphine ligands: Synthesis, DNA interactions and in vitro properties
Dennis J.M. Snelders, Angela Casini, Fabio Edafe, Gerard van Koten, Robertus J.M. Klein Gebbink and Paul J. Dyson
Journal of Organometallic Chemistry, 2011, 696, 1108
DOI: 10.1016/j.jorganchem.2010.11.025

Antimicrobial Piano‐Stool and Polypyridyl Ru(II) Complexes with Thiazolhidrazinylidene‐Chroman‐2,4‐Dione: Tautomerism, Membrane Disruption, and Electron Transport Interference
Fatlinda Rahmani, Gozde Demirci, Youri Cortat, Aurélien Crochet and Fabio Zobi
ChemBioChem, 2025, 26
DOI: 10.1002/cbic.202401025

1,3‐Dipolar Cycloaddition Reactions of Neutral and Cationic Hydridotris(pyrazolyl)borate–Ruthenium(II) Azido Complexes
Almudena García‐Fernández, Josefina Díez, M. Pilar Gamasa and Elena Lastra
Eur J Inorg Chem, 2014, 2014, 917
DOI: 10.1002/ejic.201301298

Kinetics of Aquation and Anation of Ruthenium(II) Arene Anticancer Complexes, Acidity and X‐ray Structures of Aqua Adducts
Fuyi Wang, Haimei Chen, Simon Parsons, Iain D. H. Oswald, James E. Davidson and Peter J. Sadler
Chemistry A European J, 2003, 9, 5810
DOI: 10.1002/chem.200304724

Review: Synthesis, characterization, and DNA-binding properties of Ru(II) molecular “light switch” complexes
C. Shobha Devi and S. Satyanarayana
Journal of Coordination Chemistry, 2012, 65, 474
DOI: 10.1080/00958972.2011.649736

Alkoxylation of the imine carbon atom of a Schiff-base ligand upon coordination to arene ruthenium
Wassila Aboura, Tayeb Benabdallah, Fan Zhang and Bruno Therrien
Inorganica Chimica Acta, 2018, 483, 93
DOI: 10.1016/j.ica.2018.07.025

Water soluble (η6-arene) ruthenium(II) complexes incorporating marine derived bioligand: Synthesis, spectral and structural studies
Keisham Sarjit Singh, Volodymyr Svitlyk, Prabha Devi and Yurij Mozharivskyj
Inorganica Chimica Acta, 2009, 362, 5252
DOI: 10.1016/j.ica.2009.09.006

Anthracene-Tethered Ruthenium(II) Arene Complexes as Tools To Visualize the Cellular Localization of Putative Organometallic Anticancer Compounds
Alexey A. Nazarov, Julie Risse, Wee Han Ang, Frederic Schmitt, Olivier Zava, Albert Ruggi, Michael Groessl, Rosario Scopelitti, Lucienne Juillerat-Jeanneret, Christian G. Hartinger and Paul J. Dyson
Inorg. Chem., 2012, 51, 3633
DOI: 10.1021/ic202530j

Water soluble ruthenium cyclopentadienyl and aminocyclopentadienyl PTA complexes as catalysts for selective hydrogenation of α,β-unsaturated substrates (PTA=1,3,5-triaza-7-phosphaadamantane)
Sandra Bolaño, Luca Gonsalvi, Fabrizio Zanobini, Francesco Vizza, Valerio Bertolasi, Antonio Romerosa and Maurizio Peruzzini
Journal of Molecular Catalysis A: Chemical, 2004, 224, 61
DOI: 10.1016/j.molcata.2004.06.030

Reactivity studies of η6-arene ruthenium (II) dimers with polypyridyl ligands: isolation of mono, binuclear p-cymene ruthenium (II) complexes and bisterpyridine ruthenium (II) complexes
R. Lalrempuia and Mohan Rao Kollipara
Polyhedron, 2003, 22, 3155
DOI: 10.1016/S0277-5387(03)00460-1

Towards the water solubilization of [Pt2(μ-S)2(PPh3)4] derivatives by polyether functionalization – a synthetic and mass spectrometric investigation
Neville J.A. Coughlan and William Henderson
Journal of Coordination Chemistry, 2014, 67, 3987
DOI: 10.1080/00958972.2014.893432

Important cytotoxicity of novel iron(II) cyclopentadienyl complexes with imidazole based ligands
Ana Cristina Gonçalves, Tânia S. Morais, M. Paula Robalo, Fernanda Marques, Fernando Avecilla, Cristina P. Matos, Isabel Santos, Ana Isabel Tomaz and M. Helena Garcia
Journal of Inorganic Biochemistry, 2013, 129, 1
DOI: 10.1016/j.jinorgbio.2013.07.033

Use of anethole-type ligands to design cytotoxic organometallic ruthenium compounds: An experimental and computational study
Ricardo A. Delgado, Antonio Galdámez, Catherine Tessini, Sebastián Ramírez-Rivera, Gisela Aquea, Giuliano Bernal, Balazs Pinter and Franz A. Thomet
Journal of Organometallic Chemistry, 2020, 908, 121094
DOI: 10.1016/j.jorganchem.2019.121094

Nickel(II) Complexes of 1‐Alkyl‐1‐azonia‐3,5‐diaza‐7‐phosphatricyclo[3.3.1.13,7]decane – Synthesis and Solid‐State Structures
Charles A. Mebi and Brian J. Frost
Zeitschrift anorg allge chemie, 2007, 633, 368
DOI: 10.1002/zaac.200600312

Half‐Sandwich Organometallic Ir(III) and Ru(II) Compounds and their Interactions with Biomolecules
Sandra Kozieł, Daria Wojtala, Magdalena Szmitka, Monika Lesiów, Aleksandra Ziółkowska, Jacek Sawka, Edgar Del Carpio, Debbie C. Crans and Urszula K. Komarnicka
ChemPlusChem, 2025, 90
DOI: 10.1002/cplu.202400621

DNA Binding to an Anticancer Organo-Ruthenium Complex
Marcelina Klajner, Pascal Hebraud, Claude Sirlin, Christian Gaiddon and Sebastien Harlepp
J. Phys. Chem. B, 2010, 114, 14041
DOI: 10.1021/jp1044783

Angiostatic treatment prior to chemo- or photodynamic therapy improves anti-tumor efficacy
Andrea Weiss, Débora Bonvin, Robert H. Berndsen, Edoardo Scherrer, Tse J. Wong, Paul J. Dyson, Arjan W. Griffioen and Patrycja Nowak-Sliwinska
Sci Rep, 2015, 5
DOI: 10.1038/srep08990

Polymer encapsulation of ruthenium complexes for biological and medicinal applications
Elise Villemin, Yih Ching Ong, Christophe M. Thomas and Gilles Gasser
Nat Rev Chem, 2019, 3, 261
DOI: 10.1038/s41570-019-0088-0

cis-1,3,5-Triaminocyclohexane as a Facially Capping Ligand for Ruthenium(II)
Aimee J. Gamble, Jason M. Lynam, Robert J. Thatcher, Paul H. Walton and Adrian C. Whitwood
Inorg. Chem., 2013, 52, 4517
DOI: 10.1021/ic302819j

[(p-MeC6H4Pr )2Ru2(SC6H4-p-Bu )3]Cl (diruthenium-1), a dinuclear arene ruthenium compound with very high anticancer activity: An in vitro and in vivo study
Pavel Tomšík, Darina Muthná, Martina Řezáčová, Stanislav Mičuda, Jana Ćmielová, Miloš Hroch, René Endlicher, Zuzana Červinková, Emil Rudolf, Stephan Hann, David Stíbal, Bruno Therrien and Georg Süss-Fink
Journal of Organometallic Chemistry, 2015, 782, 42
DOI: 10.1016/j.jorganchem.2014.10.050

Water‐Soluble Pd‐Imidate Complexes as Versatile Catalysts for the Modification of Unprotected Halonucleosides
José Luis Serrano
The Chemical Record, 2022, 22
DOI: 10.1002/tcr.202200179

Metal complexes with α-picolinic acid frameworks and their antitumor activity
Ljiljana E. Mihajlović-Lalić, Jelena Poljarević and Sanja Grgurić-Šipka
Inorganica Chimica Acta, 2021, 527, 120582
DOI: 10.1016/j.ica.2021.120582

Arene–Ruthenium(II) Complexes Containing 11H-Indeno[1,2-b]quinoxalin-11-one Derivatives and Tryptanthrin-6-oxime: Synthesis, Characterization, Cytotoxicity, and Catalytic Transfer Hydrogenation of Aryl Ketones
Vladislava V. Matveevskaya, Dmitry I. Pavlov, Taisiya S. Sukhikh, Artem L. Gushchin, Alexander Yu. Ivanov, Tatiana B. Tennikova, Vladimir V. Sharoyko, Sergey V. Baykov, Enrico Benassi and Andrei S. Potapov
ACS Omega, 2020, 5, 11167
DOI: 10.1021/acsomega.0c01204

Controversial Role of Transferrin in the Transport of Ruthenium Anticancer Drugs
Aviva Levina, Anthony R. M. Chetcuti and Peter A. Lay
Biomolecules, 2022, 12, 1319
DOI: 10.3390/biom12091319

Substitution‐Modulated Anticancer Activity of Half‐Sandwich Ruthenium(II) Complexes with Heterocyclic Ancillary Ligands
Raja Mitra and Ashoka G. Samuelson
Eur J Inorg Chem, 2014, 2014, 3536
DOI: 10.1002/ejic.201402205

Bioorganometallic Chemistry. 27. Synthetic, X-ray Crystallographic, and Competitive Binding Studies in the Reactions of Nucleobases, Nucleosides, and Nucleotides with [Cp*Rh(H2O)3](OTf)2, as a Function of pH, and the Utilization of Several Cp*Rh–DNA Base Complexes in Host–Guest Chemistry
David P. Smith, Hong Chen, Seiji Ogo, Ana I. Elduque, Miriam Eisenstein, Marilyn M. Olmstead and Richard H. Fish
Organometallics, 2014, 33, 2389
DOI: 10.1021/om500106r

Water-soluble arene ruthenium complexes containing pyridinethiolato ligands: Synthesis, molecular structure, redox properties and anticancer activity of the cations [(η6-arene)Ru(p-SC5H4NH)3]2+
Michaël Gras, Bruno Therrien, Georg Süss-Fink, Petr Štěpnička, Anna K. Renfrew and Paul J. Dyson
Journal of Organometallic Chemistry, 2008, 693, 3419
DOI: 10.1016/j.jorganchem.2008.08.004

Piano stool Ru(II)-arene complexes having three monodentate legs: A comprehensive review on their development as anticancer therapeutics over the past decade
Srividya Swaminathan, Jebiti Haribabu, Nithya Balakrishnan, Punitharaj Vasanthakumar and Ramasamy Karvembu
Coordination Chemistry Reviews, 2022, 459, 214403
DOI: 10.1016/j.ccr.2021.214403

Recent advances in Rh(III)-based anticancer complexes
Souvik Saha, Rajesh Kushwaha, Apurba Mandal, Nidhi Singh and Samya Banerjee
Coordination Chemistry Reviews, 2025, 525, 216306
DOI: 10.1016/j.ccr.2024.216306

Discovery of a low order drug-cell response surface for applications in personalized medicine
Xianting Ding, Wenjia Liu, Andrea Weiss, Yiyang Li, Ieong Wong, Arjan W Griffioen, Hubert van den Bergh, Hongquan Xu, Patrycja Nowak-Sliwinska and Chih-Ming Ho
Phys. Biol., 2014, 11, 065003
DOI: 10.1088/1478-3975/11/6/065003

Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA = 1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties
F. Battistin, F. Scaletti, G. Balducci, S. Pillozzi, A. Arcangeli, L. Messori and E. Alessio
Journal of Inorganic Biochemistry, 2016, 160, 180
DOI: 10.1016/j.jinorgbio.2016.02.009

Ruthenium and Osmium Complexes of Phosphine-Porphyrin Derivatives as Potential Bimetallic Theranostics: Photophysical Studies
Pierre D. Harvey, Semra Tasan, Claude P. Gros, Charles H. Devillers, Philippe Richard, Pierre Le Gendre and Ewen Bodio
Organometallics, 2015, 34, 1218
DOI: 10.1021/om5011808

Osmium Arene Germyl, Stannyl, Germanate, and Stannate Complexes as Anticancer Agents
Tomiris Nabiyeva, Basile Roufosse, Matylda Odachowski, Judith Baumgartner, Christoph Marschner, Akalesh Kumar Verma and Burgert Blom
ACS Omega, 2021, 6, 19252
DOI: 10.1021/acsomega.1c02665

Binding of piano‐stool Ru(II) complexes to DNA; QM/MM study
Zdeněk Futera, James A. Platts and Jaroslav V. Burda
J Comput Chem, 2012, 33, 2092
DOI: 10.1002/jcc.23045

Synthesis and biological activity of ferrocenyl indeno[1,2-c]isoquinolines as topoisomerase II inhibitors
Nathalie Wambang, Nadège Schifano-Faux, Alexandre Aillerie, Brigitte Baldeyrou, Camille Jacquet, Christine Bal-Mahieu, Till Bousquet, Sylvain Pellegrini, Peter T. Ndifon, Samuel Meignan, Jean-François Goossens, Amélie Lansiaux and Lydie Pélinski
Bioorganic & Medicinal Chemistry, 2016, 24, 651
DOI: 10.1016/j.bmc.2015.12.033

Study of $\boldsymbol{\eta}^{\bf 6}$ - cyclic $\boldsymbol{\pi} $ -perimeter hydrocarbon ruthenium complexes bearing functionalized pyridyl diketones: Isolation of complexes with $\boldsymbol{\kappa}^\textbf{2}$ -N∩O and $\boldsymbol{\kappa}^\textbf{4}$ -N∩O bonding modes of ligands
SAPHIDABHA L NONGBRI, BABULAL DAS and MOHAN RAO KOLLIPARA
J Chem Sci, 2012, 124, 1365
DOI: 10.1007/s12039-012-0337-y

Synthesis and characterisation of some water soluble ruthenium(II)–arene complexes and an investigation of their antibiotic and antiviral properties
Claire S Allardyce, Paul J Dyson, David J Ellis, Paul A Salter and Rosario Scopelliti
Journal of Organometallic Chemistry, 2003, 668, 35
DOI: 10.1016/S0022-328X(02)01926-5

Exploration of various electronic properties along the reaction coordinate for hydration of Pt(II) and Ru(II) complexes; the CCSD, MPx, and DFT computational study
Jaroslav V. Burda, Zdeněk Futera and Zdeněk Chval
J Mol Model, 2013, 19, 5245
DOI: 10.1007/s00894-013-1994-6

Syntheses of (η 6 - p -cymene)ruthenium(II) piano-stool amine complexes: molecular structure of [(η 6 -C 10 H 14 )RuCl 2 (H 2 N-C 6 H 4 - p -Cl)]
Padavattan Govindaswamy and Mohan Rao Kollipara
Journal of Coordination Chemistry, 2005, 59, 131
DOI: 10.1080/00958970500266040

Synthesis, molecular, crystal and electronic structure of [(C6H6)Ru(1,2,4-triazole)3](CF3SO3)2
J. G. Małecki, R. Kruszynski, M. Jaworska and P. Lodowski
Journal of Coordination Chemistry, 2007, 60, 741
DOI: 10.1080/00958970600914796

Synthesis, characterization and interactions with 9-methylguanine of ruthenium(II) η6-arene complexes with aromatic diimines
Theodoros Tsolis, Konstantinos Ypsilantis, Andreas Kourtellaris and Achilleas Garoufis
Polyhedron, 2018, 149, 45
DOI: 10.1016/j.poly.2018.04.025

Seleno‐Nucleobases and Their Water‐Soluble Ruthenium–Arene Half‐Sandwich Complexes: Chemistry and Biological Activity
Raja Mitra, Anup K. Pramanik and Ashoka G. Samuelson
Eur J Inorg Chem, 2014, 2014, 5733
DOI: 10.1002/ejic.201402412

Quantum Chemical Investigation on Hydrolysis of Orally Active Organometallic Ruthenium(II) and Osmium(II) Anticancer Drugs and Their Interaction with Histidine
Amit Kumar Pradhan, Abhijit Shyam, Abhijit Dutta and Paritosh Mondal
J. Phys. Chem. B, 2022, 126, 9516
DOI: 10.1021/acs.jpcb.2c05062

Emerging Protein Targets for Anticancer Metallodrugs: Inhibition of Thioredoxin Reductase and Cathepsin B by Antitumor Ruthenium(II)−Arene Compounds
Angela Casini, Chiara Gabbiani, Francesca Sorrentino, Maria Pia Rigobello, Alberto Bindoli, Tilmann J. Geldbach, Alessandro Marrone, Nazzareno Re, Christian G. Hartinger, Paul J. Dyson and Luigi Messori
J. Med. Chem., 2008, 51, 6773
DOI: 10.1021/jm8006678

Dinuclear Ruthenium Ethylene Complexes: Syntheses, Structures, and Catalytic Applications in ATRA and ATRC Reactions
Joffrey Wolf, Katrin Thommes, Oliver Briel, Rosario Scopelliti and Kay Severin
Organometallics, 2008, 27, 4464
DOI: 10.1021/om8004096

A ruthenium complexes of monastrol and its pyrimidine analogues: Synthesis and biological properties
Wasfi A. Al-Masoudi and Najim A. Al-Masoudi
Phosphorus, Sulfur, and Silicon and the Related Elements, 2019, 194, 1020
DOI: 10.1080/10426507.2019.1597362

Modulation of ruthenium anticancer drugs analogs with tolfenamic acid: Reactivity, biological interactions and growth inhibition of yeast cell
Priyaranjan Kumar, Swati Swagatika, Srikanth Dasari, Raghuvir Singh Tomar and Ashis K. Patra
Journal of Inorganic Biochemistry, 2019, 199, 110769
DOI: 10.1016/j.jinorgbio.2019.110769

Drug Conjugation to Cyclic Peptide–Polymer Self‐Assembling Nanotubes
Bianca M. Blunden , Robert Chapman, Maarten Danial, Hongxu Lu, Katrina A. Jolliffe, Sébastien Perrier  and Martina H. Stenzel
Chemistry A European J, 2014, 20, 12745
DOI: 10.1002/chem.201403130

Synthetic and Mechanistic Pathways of Cis and Trans-Hydroxytamoxifen Drug Derivatives Reacting with Cp*Rh Complexes that involve η1-N, η2-N,O, η1-O, and η6 Bonding Modes, via a Novel N-π Rearrangement; Relative Binding Affinities and Computer Docking Studies of Cis and Trans-η6-Cp*Rh-Hydroxytamoxifen Complexes at the Estrogen, ERα and ERβ Receptors, and Growth Inhibition to Breast Cancer Cells
Siden Top, Irena Efremenko, Marie Noelle Rager, Anne Vessières, Paul Yaswen, Gérard Jaouen and Richard H. Fish
Inorg. Chem., 2011, 50, 271
DOI: 10.1021/ic1019372

Ruthenium(II) p-cymene complex bearing 2,2′-dipyridylamine targets caspase 3 deficient MCF-7 breast cancer cells without disruption of antitumor immune response
Goran N. Kaluđerović, Tamara Krajnović, Miljana Momcilovic, Stanislava Stosic-Grujicic, Sanja Mijatović, Danijela Maksimović-Ivanić and Evamarie Hey-Hawkins
Journal of Inorganic Biochemistry, 2015, 153, 315
DOI: 10.1016/j.jinorgbio.2015.09.006

Tuning Heavy Metal Compounds for Anti-Tumor Activity: Is Diversity the Key to Ruthenium’s Success?
Simon M Page, Sally R Boss and Paul D Barker
Future Med. Chem., 2009, 1, 541
DOI: 10.4155/fmc.09.25

Chemo‐Genetic Optimization of DNA Recognition by Metallodrugs using a Presenter‐Protein Strategy
Jeremy M. Zimbron, Alessia Sardo, Tillmann Heinisch, Therese Wohlschlager, Julieta Gradinaru, Claudia Massa, Tilman Schirmer, Marc Creus and Thomas R. Ward
Chemistry A European J, 2010, 16, 12883
DOI: 10.1002/chem.201001573

Anti-inflammatory activity of electron-deficient organometallics
Jingwen Zhang, Anaïs Pitto-Barry, Lijun Shang and Nicolas P. E. Barry
R. Soc. open sci., 2017, 4, 170786
DOI: 10.1098/rsos.170786

Research Progress of Metal Anticancer Drugs
Yun Bai, Gerile Aodeng, Lu Ga, Wenfeng Hai and Jun Ai
Pharmaceutics, 2023, 15, 2750
DOI: 10.3390/pharmaceutics15122750

Synthesis, Characterization, and DNA Binding of New Water-Soluble Cyclopentadienyl Ruthenium(II) Complexes Incorporating Phosphines
Antonio Romerosa, Tatiana Campos-Malpartida, Chaker Lidrissi, Mustapha Saoud, Manuel Serrano-Ruiz, Maurizio Peruzzini, Jose Antonio Garrido-Cárdenas and Federico García-Maroto
Inorg. Chem., 2006, 45, 1289
DOI: 10.1021/ic051053q

Studies of the Antiproliferative Activity of Ruthenium (II) Cyclopentadienyl‐Derived Complexes with Nitrogen Coordinated Ligands
Virtudes Moreno, Julia Lorenzo, Francesc X. Aviles, M. Helena Garcia, João P. Ribeiro, Tânia S. Morais, Pedro Florindo, M. Paula Robalo and Spyros P. Perlepes
Bioinorganic Chemistry and Applications, 2010, 2010
DOI: 10.1155/2010/936834

Comparison of hydration reactions for “piano-stool” RAPTA-B and [Ru(η6− arene)(en)Cl]+ complexes: Density functional theory computational study
Zdeněk Chval, Zdeněk Futera and Jaroslav V. Burda
The Journal of Chemical Physics, 2011, 134
DOI: 10.1063/1.3515534

X-ray crystallographic investigation and biological activities of Ru(III) complexes containing Schiff base and triphenyl phosphine/arsine
Rathinasabapathi Prabhakaran, Rui Huang and Karuppannan Natarajan
Inorganica Chimica Acta, 2006, 359, 3359
DOI: 10.1016/j.ica.2006.03.032

Photoswitchable arene ruthenium and pentamethylcyclopentadienyl rhodium complexes containing o-sulfonamide azobenzene ligands: Synthesis, characterization and cytotoxicity
Claire Deo, Huan Wang, Nicolas Bogliotti, Yi Zang, Pascal Retailleau, Xiao-Peng He, Jia Li and Juan Xie
Journal of Organometallic Chemistry, 2016, 820, 111
DOI: 10.1016/j.jorganchem.2016.07.009

Arene ruthenium complexes with phosphinoferrocene amino acid conjugates: Synthesis, characterization and cytotoxicity
Jiří Tauchman, Georg Süss-Fink, Petr Štěpnička, Oliver Zava and Paul J. Dyson
Journal of Organometallic Chemistry, 2013, 723, 233
DOI: 10.1016/j.jorganchem.2012.10.009

Evaluation of the Antiproliferative Properties of CpRu Complexes Containing N-Methylated Triazaphosphaadamantane Derivatives
Andres Alguacil, Franco Scalambra, Antonio Romerosa, Andreia Bento-Oliveira, Fernanda Marques, Ines Maximiano, Rodrigo F. M. de Almeida, Ana Isabel Tomaz, Andreia Valente and Franc Perdih
Bioinorganic Chemistry and Applications, 2023, 2023, 1
DOI: 10.1155/2023/6669394

The development of RAPTA compounds for the treatment of tumors
Benjamin S. Murray, Maria V. Babak, Christian G. Hartinger and Paul J. Dyson
Coordination Chemistry Reviews, 2016, 306, 86
DOI: 10.1016/j.ccr.2015.06.014

Novel multitopic diphos-type ligands.
Peter C. Kunz, Corinna Wetzel, Melanie Bongartz, Anna Louisa Noffke and Bernhard Spingler
Journal of Organometallic Chemistry, 2010, 695, 1891
DOI: 10.1016/j.jorganchem.2010.04.028

Development of Bimetallic Titanocene−Ruthenium−Arene Complexes As Anticancer Agents: Relationships between Structural and Biological Properties
Frédéric Pelletier, Virginie Comte, Alexandre Massard, Margot Wenzel, Stéphanie Toulot, Philippe Richard, Michel Picquet, Pierre Le Gendre, Olivier Zava, Fabio Edafe, Angela Casini and Paul J. Dyson
J. Med. Chem., 2010, 53, 6923
DOI: 10.1021/jm1004804

Influence of Hydrogen-Bonding Substituents on the Cytotoxicity of RAPTA Compounds
Claudine Scolaro, Tilmann J. Geldbach, Sébastien Rochat, Antoine Dorcier, Christian Gossens, Alberta Bergamo, Moreno Cocchietto, Ivano Tavernelli, Gianni Sava, Ursula Rothlisberger and Paul J. Dyson
Organometallics, 2006, 25, 756
DOI: 10.1021/om0508841

Hydrolysis study of the bifunctional antitumour compound RAPTA-C, [Ru(η6-p-cymene)Cl2(pta)]
Claudine Scolaro, Christian G. Hartinger, Claire S. Allardyce, Bernhard K. Keppler and Paul J. Dyson
Journal of Inorganic Biochemistry, 2008, 102, 1743
DOI: 10.1016/j.jinorgbio.2008.05.004

Structures, preparation and catalytic activity of ruthenium cyclopentadienyl complexes based on pyridyl-phosphine ligand
Prashant Kumar, Ashish Kumar Singh, Sanjeev Sharma and Daya Shankar Pandey
Journal of Organometallic Chemistry, 2009, 694, 3643
DOI: 10.1016/j.jorganchem.2009.07.011

Highly Cytotoxic Ruthenium(II)-Arene Complexes from Bulky 1-Pyrenylphosphane Ligands
Rosa F. Brissos, Pau Clavero, Albert Gallen, Arnald Grabulosa, Leoní A. Barrios, Ana B. Caballero, Luís Korrodi-Gregório, Ricardo Pérez-Tomás, Guillermo Muller, Vanessa Soto-Cerrato and Patrick Gamez
Inorg. Chem., 2018, 57, 14786
DOI: 10.1021/acs.inorgchem.8b02541

Synthesis of organometallic ruthenium(II) complexes with strong activity against several human cancer cell lines
Tânia S. Morais, Tiago J.L. Silva, Fernanda Marques, M. Paula Robalo, Fernando Avecilla, Paulo J. Amorim Madeira, Paulo J.G. Mendes, Isabel Santos and M. Helena Garcia
Journal of Inorganic Biochemistry, 2012, 114, 65
DOI: 10.1016/j.jinorgbio.2012.04.014

Synthesis and characterization of a diruthenium(II,III)–ketoprofen compound and study of the in vitro effects on CRC cells in comparison to the naproxen and ibuprofen derivatives
Rodrigo L.S.R. Santos, Alberta Bergamo, Gianni Sava and Denise de Oliveira Silva
Polyhedron, 2012, 42, 175
DOI: 10.1016/j.poly.2012.05.012

Synthesis, characterization, HSA/DNA interactions and antitumor activity of new [Ru(η6-p-cymene)Cl2(L)] complexes
Maja B. Đukić, Marija S. Jeremić, Ignjat P. Filipović, Olivera R. Klisurić, Vesna V. Kojić, Dimitar S. Jakimov, Ratomir M. Jelić, Valentina Onnis and Zoran D. Matović
Journal of Inorganic Biochemistry, 2020, 213, 111256
DOI: 10.1016/j.jinorgbio.2020.111256

Opening the lid on piano-stool complexes: An account of ruthenium(II)–arene complexes with medicinal applications
Alexey A. Nazarov, Christian G. Hartinger and Paul J. Dyson
Journal of Organometallic Chemistry, 2014, 751, 251
DOI: 10.1016/j.jorganchem.2013.09.016

Enhanced Antimetastatic Activity of the Ruthenium Anticancer Drug RAPTA‐C Delivered in Fructose‐Coated Micelles
Mingxia Lu, Fan Chen, Janina‐Miriam Noy, Hongxu Lu and Martina H. Stenzel
Macromolecular Bioscience, 2017, 17
DOI: 10.1002/mabi.201600513

Homo and heteromultimetallic complexes containing a group 8 transition metal and μ-diphosphine bridging ligands involved in anticancer research: A review
Basile Roufosse, Christi Serbu, Christoph Marschner, Sharon Prince and Burgert Blom
European Journal of Medicinal Chemistry, 2024, 274, 116528
DOI: 10.1016/j.ejmech.2024.116528

Coordination chemistry of 1,3,5-triaza-7-phosphaadamantane (PTA)
Andrew D. Phillips, Luca Gonsalvi, Antonio Romerosa, Francesco Vizza and Maurizio Peruzzini
Coordination Chemistry Reviews, 2004, 248, 955
DOI: 10.1016/j.ccr.2004.03.010

The synthesis, structural characterization, and in vitro anti-cancer activity of chloro(p-cymene) complexes of ruthenium(II) containing a disulfoxide ligand
Lynsey A. Huxham, Elizabeth L.S. Cheu, Brian O. Patrick and Brian R. James
Inorganica Chimica Acta, 2003, 352, 238
DOI: 10.1016/S0020-1693(03)00155-5

In situ NMR characterisation of an intermediate in the catalytic hydrogenation of CO2 and HCO3- in aqueous solution
Gábor Laurenczy, Stephanie Jedner, Enzo Alessio and Paul J. Dyson
Inorganic Chemistry Communications, 2007, 10, 558
DOI: 10.1016/j.inoche.2007.01.020

Pyridine and pyrimidine functionalized half-sandwich Ru(II)-N heterocyclic carbene complexes: Synthesis, structures, spectra, electrochemistry and biological studies
Bidyut K. Rana, Gourisankar Roymahapatra, Himadri Sekhar Das, Santanab Giri, Marlon H. Cardoso, Octávio L. Franco, N.K. Kiran, Manas K. Santra, Partha Pratim Bag, Valerio Bertolasi and Joydev Dinda
Journal of Molecular Structure, 2021, 1231, 129822
DOI: 10.1016/j.molstruc.2020.129822

Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted Chemotherapy
Wee Han Ang and Paul J. Dyson
Eur J Inorg Chem, 2006, 2006, 4003
DOI: 10.1002/ejic.200600723

Synthesis, Characterization, and in Vitro Cytotoxicity of Some Gold(I) and Trans Platinum(II) Thionate Complexes Containing Water-Soluble PTA and DAPTA Ligands. X-ray Crystal Structures of [Au(SC4H3N2)(PTA)],trans-[Pt(SC4H3N2)2(PTA)2],trans-[Pt(SC5H4N)2(PTA)2], andtrans-[Pt(SC5H4N)2(DAPTA)2]
Susana Miranda, Elena Vergara, Fabian Mohr, Dick de Vos, Elena Cerrada, Aránzazu Mendía and Mariano Laguna
Inorg. Chem., 2008, 47, 5641
DOI: 10.1021/ic7021903

Off–on–off pH luminescence switching and DNA binding properties of a free terpyridine-appended ruthenium complex
Ze-Bao Zheng, Si-Yuan Kang, Xun Yi, Na Zhang and Ke-Zhi Wang
Journal of Inorganic Biochemistry, 2014, 141, 70
DOI: 10.1016/j.jinorgbio.2014.08.010

Influence of Structural Variation on the Anticancer Activity of RAPTA-Type Complexes: ptn versus pta
Anna K. Renfrew, Andrew D. Phillips, Alexander E. Egger, Christian G. Hartinger, Sylvain S. Bosquain, Alexey A. Nazarov, Bernhard K. Keppler, Luca Gonsalvi, Maurizio Peruzzini and Paul J. Dyson
Organometallics, 2009, 28, 1165
DOI: 10.1021/om800899e

Cyclometalated platinum(II) complexes containing monodentate phosphines: antiproliferative study
Hamidreza Samouei, Mehdi Rashidi and Frank W. Heinemann
J IRAN CHEM SOC, 2014, 11, 1207
DOI: 10.1007/s13738-013-0389-z

1,3,5‐Triaza‐7‐phosphaadamantane (PTA) Derived Caged Phosphines for Palladium‐Catalyzed Selective Functionalization of Nucleosides and Heteroarenes
Siva Sankar Murthy Bandaru, Shatrughn Bhilare, Carola Schulzke and Anant R. Kapdi
The Chemical Record, 2021, 21, 188
DOI: 10.1002/tcr.202000109

Evaluation of heteroscorpionate ligands as scaffolds for the generation of Ruthenium(II) metallodrugs in breast cancer therapy
Elena Domínguez-Jurado, Consuelo Ripoll, Agustín Lara-Sánchez, Alberto Ocaña, Iñigo J. Vitórica-Yrezábal, Iván Bravo and Carlos Alonso-Moreno
Journal of Inorganic Biochemistry, 2024, 253, 112486
DOI: 10.1016/j.jinorgbio.2024.112486

Coordination Chemistry of the (η6-p-Cymene)ruthenium(II) Fragment with Bis-, Tris-, and Tetrakis(pyrazol-1-yl)borate Ligands: Synthesis, Structural, Electrochemical, and Catalytic Diastereoselective Nitroaldol Reaction Studies
Claudio Pettinari, Fabio Marchetti, Adele Cerquetella, Riccardo Pettinari, Magda Monari, Tatiana C. O. Mac Leod, Luísa M. D. R. S. Martins and Armando J. L. Pombeiro
Organometallics, 2011, 30, 1616
DOI: 10.1021/om101146q

In Vitro and in Vivo Evaluation of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential Chemotherapeutic Agent for Triple Negative Breast Cancer
Malgorzata Frik, Alberto Martínez, Benelita T. Elie, Oscar Gonzalo, Daniel Ramírez de Mingo, Mercedes Sanaú, Roberto Sánchez-Delgado, Tanmoy Sadhukha, Swayam Prabha, Joe W. Ramos, Isabel Marzo and María Contel
J. Med. Chem., 2014, 57, 9995
DOI: 10.1021/jm5012337

From traditional PTA to novel CAP: A comparison between two adamantane cage-type aminophosphines
Antonella Guerriero and Luca Gonsalvi
Inorganica Chimica Acta, 2021, 518, 120251
DOI: 10.1016/j.ica.2021.120251

Ruthenium(II)–Arene Complexes with Strong Fluorescence: Insight into the Underlying Mechanism
Qianxiong Zhou, Wanhua Lei, Yongjie Chen, Chao Li, Yuanjun Hou, Baowen Zhang and Xuesong Wang
Chemistry A European J, 2012, 18, 8617
DOI: 10.1002/chem.201200960

Bis-amide transition metal complexes: Isomerism and DNA interaction study
Natarajan Raman and Ramasubbu Rajakumar
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2014, 120, 428
DOI: 10.1016/j.saa.2013.10.037

Synthesis of Metal‐Carbonyl–Dendrimer–Antibody Immunoconjugates: Towards a New Format for Carbonyl Metallo Immunoassay
Nathalie Fischer‐Durand, Michèle Salmain, Bogna Rudolf, Anne Vessières, Janusz Zakrzewski and Gérard Jaouen
ChemBioChem, 2004, 5, 519
DOI: 10.1002/cbic.200300800

Transfer hydrogenation of citral to citronellol with Ru complexes in the mixed solvent of water and polyethylene glycol
Haiyang Cheng, Ruixia Liu, Jianmin Hao, Qiang Wang, Yancun Yu, Shuxia Cai and Fengyu Zhao
Applied Organom Chemis, 2010, 24, 763
DOI: 10.1002/aoc.1694

Mono- and di-nuclear azido η6-p-cymene ruthenium(II) complexes; synthesis, reactivity, and structures
R. Lalrempuia, Hemant P. Yennawar and Mohan Rao Kollipara
Journal of Coordination Chemistry, 2009, 62, 3661
DOI: 10.1080/00958970903154470

Anti-metastatic effects of RAPTA-C conjugated polymeric micelles on two-dimensional (2D) breast tumor cells and three-dimensional (3D) multicellular tumor spheroids
Hongxu Lu, Bianca M. Blunden, Wei Scarano, Mingxia Lu and Martina H. Stenzel
Acta Biomaterialia, 2016, 32, 68
DOI: 10.1016/j.actbio.2015.12.020

From Sunscreen to Anticancer Agent: Ruthenium(II) Arene Avobenzone Complexes Display Potent Anticancer Activity
Riccardo Pettinari, Fabio Marchetti, Agnese Petrini, Claudio Pettinari, Giulio Lupidi, Piotr Smoleński, Rosario Scopelliti, Tina Riedel and Paul J. Dyson
Organometallics, 2016, 35, 3734
DOI: 10.1021/acs.organomet.6b00694

Insights into the κ-P,N Coordination of 1,3,5-Triaza-7-phosphaadamantane and Derivatives: κ-P,N-Heterometallic Complexes and a 15N Nuclear Magnetic Resonance Survey
Andrés Alguacil, Franco Scalambra and Antonio Romerosa
Inorg. Chem., 2022, 61, 5779
DOI: 10.1021/acs.inorgchem.1c03831

Diffusion NMR Studies on the Self-Aggregation of Ru-Arene CAP Complexes: Evidence for the Formation of H-Bonded Dicationic Species in Acetonitrile
Leonardo Sian, Antonella Guerriero, Maurizio Peruzzini, Cristiano Zuccaccia, Luca Gonsalvi and Alceo Macchioni
Organometallics, 2020, 39, 941
DOI: 10.1021/acs.organomet.9b00703

Investigation of the Effects and Mechanisms of Anticancer Action of a Ru(II)‐Arene Iminophosphorane Compound in Triple Negative Breast Cancer Cells
Nazia Nayeem, Arefa Yeasmin, Samantha N. Cobos, Ali Younes, Karen Hubbard and Maria Contel
ChemMedChem, 2021, 16, 3280
DOI: 10.1002/cmdc.202100325

Anticancer and Antibacterial Activity Studies of Gold(I)-Alkynyl Chromones
Paweł Hikisz, Łukasz Szczupak, Aneta Koceva-Chyła, Adam Guśpiel, Luciano Oehninger, Ingo Ott, Bruno Therrien, Jolanta Solecka and Konrad Kowalski
Molecules, 2015, 20, 19699
DOI: 10.3390/molecules201119647

Cytotoxicity of η-areneruthenium-based molecules to glioblastoma cells and their recognition by multidrug ABC transporters
Jaqueline Pazinato, Otávio M. Cruz, Karine P. Naidek, Amanda R.A. Pires, Eduard Westphal, Hugo Gallardo, Hélène Baubichon-Cortay, Maria E.M. Rocha, Glaucia R. Martinez, Sheila M.B. Winnischofer, Attilio Di Pietro and Herbert Winnischofer
European Journal of Medicinal Chemistry, 2018, 148, 165
DOI: 10.1016/j.ejmech.2018.02.026

The ruthenium(II)–arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53–JNK pathways
Soumya Chatterjee, Subhadip Kundu, Arindam Bhattacharyya, Christian G. Hartinger and Paul J. Dyson
J Biol Inorg Chem, 2008, 13, 1149
DOI: 10.1007/s00775-008-0400-9

Enhanced Delivery of the RAPTA-C Macromolecular Chemotherapeutic by Conjugation to Degradable Polymeric Micelles
Bianca M. Blunden, Hongxu Lu and Martina H. Stenzel
Biomacromolecules, 2013, 14, 4177
DOI: 10.1021/bm4013919

Development of organometallic (organo-transition metal) pharmaceuticals
Claire S. Allardyce, Antoine Dorcier, Claudine Scolaro and Paul J. Dyson
Appl. Organometal. Chem., 2005, 19, 1
DOI: 10.1002/aoc.725

DNA-binding, antioxidant activity and in vitro cytotoxicity induced by ruthenium(II) complexes containing polypyridyl ligands
Cheng-Hui Zeng, Yun-Jun Liu, Zheng-Zheng Li, Zhen-Hua Liang, Hong-Liang Huang and Fu-Hai Wu
Transition Met Chem, 2010, 35, 731
DOI: 10.1007/s11243-010-9386-6

Invertierte “Klavierstühle” – ein molekulares Erkennungsmotiv, das die 1:1‐Cokristallisation von zwei Diastereomeren im selben Einkristall erzwingt
Henri Brunner, Matthias Weber, Manfred Zabel and Thomas Zwack
Angewandte Chemie, 2003, 115, 1903
DOI: 10.1002/ange.200250181

Medicinal applications of vanadium complexes with Schiff bases
Kulsum Hashmi, Satya, Sakshi Gupta, Armeen Siddique, Tahmeena Khan and Seema Joshi
Journal of Trace Elements in Medicine and Biology, 2023, 79, 127245
DOI: 10.1016/j.jtemb.2023.127245

Half sandwiched RutheniumII complexes: En Route towards the targeted delivery by Human Serum Albumin (HSA)
Suboot Hairat and Mehvash Zaki
Journal of Organometallic Chemistry, 2021, 937, 121732
DOI: 10.1016/j.jorganchem.2021.121732

Hydroxylation of azomethine carbon: isolation of complexes of η5 and η6-cyclic hydrocarbon platinum group metals with a new Schiff-base ligand
Sairem Gloria, Gajendra Gupta, Venkateswara Rao Anna, Babulal Das and Kollipara Mohan Rao
Journal of Coordination Chemistry, 2011, 64, 4168
DOI: 10.1080/00958972.2011.636427

Synthesis, crystal structures, DNA-binding properties, cytotoxic and antioxidation activities of several new ternary copper(II) complexes of N,N′-(p-xylylene)di-alanine acid and 1,10-phenanthroline
Lei Jia, Peng Jiang, Jun Xu, Zhong-yan Hao, Xi-ming Xu, Long-hai Chen, Jin-cai Wu, Ning Tang, Qin Wang and Jagadese J. Vittal
Inorganica Chimica Acta, 2010, 363, 855
DOI: 10.1016/j.ica.2009.12.047

Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma
Magdalena Rausch, Adriano Rutz, Pierre-Marie Allard, Céline Delucinge-Vivier, Mylène Docquier, Olivier Dormond, Paul J. Dyson, Jean-Luc Wolfender and Patrycja Nowak-Sliwinska
Cancers, 2021, 13, 3978
DOI: 10.3390/cancers13163978

A bioorganometallic chemistry perspective: Organometallic chemistry at the interface with biology
Richard H. Fish
Journal of Organometallic Chemistry, 2015, 782, 3
DOI: 10.1016/j.jorganchem.2014.10.034

Synthesis, structure, spectral, redox properties and anti-cancer activity of Ruthenium(II) Arene complexes with substituted Triazole Ligands
Arabinda Muley, Kalai Selvan Karumban, Parth Gupta, Sadananda Kumbhakar, Bishnubasu Giri, Rajnikant Raut, Ashish Misra and Somnath Maji
Journal of Organometallic Chemistry, 2021, 954-955, 122074
DOI: 10.1016/j.jorganchem.2021.122074

Is the Aromatic Fragment of Piano‐Stool Ruthenium Compounds an Essential Feature for Anticancer Activity? The Development of New RuII‐[9]aneS3Analogues
Barbara Serli, Ennio Zangrando, Teresa Gianferrara, Claudine Scolaro, Paul J. Dyson, Alberta Bergamo and Enzo Alessio
Eur J Inorg Chem, 2005, 2005, 3423
DOI: 10.1002/ejic.200500210

Synthesis, antiproliferative activity and apoptosis-promoting effects of arene ruthenium(II) complexes with N, O chelating ligands
Nanjan Mohan, Mohamed Kasim Mohamed Subarkhan and Rengan Ramesh
Journal of Organometallic Chemistry, 2018, 859, 124
DOI: 10.1016/j.jorganchem.2018.01.022

Development and future prospects of selective organometallic compounds as anticancer drug candidates exhibiting novel modes of action
Sabiha Parveen, Farukh Arjmand and Sartaj Tabassum
European Journal of Medicinal Chemistry, 2019, 175, 269
DOI: 10.1016/j.ejmech.2019.04.062

A streamlined search technology for identification of synergistic drug combinations
Andrea Weiss, Robert H. Berndsen, Xianting Ding, Chih-Ming Ho, Paul J. Dyson, Hubert van den Bergh, Arjan W. Griffioen and Patrycja Nowak-Sliwinska
Sci Rep, 2015, 5
DOI: 10.1038/srep14508

An efficient synthesis and in vitro antibacterial evaluation of ruthenium–quinolinol complexes
Mahima Malipeddi, Chirag Lakhani, Mohit Chhabra, Priyankar Paira and R. Vidya
Bioorganic & Medicinal Chemistry Letters, 2015, 25, 2892
DOI: 10.1016/j.bmcl.2015.05.063

State of the art in organometallic ruthenium metallodrugs for breast cancer treatment: Advances and innovations
Elena Domínguez-Jurado, Agustín Lara-Sánchez, Iván Bravo, Alberto Ocaña and Carlos Alonso-Moreno
Coordination Chemistry Reviews, 2025, 523, 216252
DOI: 10.1016/j.ccr.2024.216252

Competitive binding studies of the nucleosomal histone targeting drug, [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C), with oligonucleotide-peptide mixtures.
Farangis Mansouri, Daniel Ortiz and Paul J. Dyson
Journal of Inorganic Biochemistry, 2023, 238, 112043
DOI: 10.1016/j.jinorgbio.2022.112043

1H HR-MAS NMR Based Metabolic Profiling of Cells in Response to Treatment with a Hexacationic Ruthenium Metallaprism as Potential Anticancer Drug
Martina Vermathen, Lydia E. H. Paul, Gaëlle Diserens, Peter Vermathen, Julien Furrer and Daniel Monleon
PLoS ONE, 2015, 10, e0128478
DOI: 10.1371/journal.pone.0128478

Polymeric Nanoparticles Containing Ruthenium Complexes for Biomedical Applications: A Mini-Review on Recent Developments
Anaïs Pitto-Barry
ACS Appl. Polym. Mater., 2024, 6, 14133
DOI: 10.1021/acsapm.4c00494

Approaching tumour therapy beyond platinum drugs
A. Bergamo, C. Gaiddon, J.H.M. Schellens, J.H. Beijnen and G. Sava
Journal of Inorganic Biochemistry, 2012, 106, 90
DOI: 10.1016/j.jinorgbio.2011.09.030

Synthesis, molecular, crystal and electronic structure of [(C6H6)RuCl(1,10-C12H8N2)]Cl
J.G. Małecki, M. Jaworska and R. Kruszynski
Journal of Organometallic Chemistry, 2007, 692, 2903
DOI: 10.1016/j.jorganchem.2007.02.048

Water-soluble arene ruthenium complexes: From serendipity to catalysis and drug design
Georg Süss-Fink
Journal of Organometallic Chemistry, 2014, 751, 2
DOI: 10.1016/j.jorganchem.2013.07.039

Synthesis and in vitro anticancer studies of arene ruthenium(II) and arene osmium(II) complexes bearing arsine and stibine co-ligands on breast cancer cell-lines
Stefan Latiş, Christoph Marschner, Judith Baumgartner, Sharon Prince, Supratim Biswas, Suparna Chakraborty, Kimberly G. Garcia, Ron M.A. Heeren, Sebastiaan Van Nuffel and Burgert Blom
Journal of Organometallic Chemistry, 2023, 1001, 122891
DOI: 10.1016/j.jorganchem.2023.122891

Increasing Anticancer Activity with Phosphine Ligation in Zwitterionic Half-Sandwich Iridium(III), Rhodium(III), and Ruthenium(II) Complexes
Xueyan Hu, Lihua Guo, Mengqi Liu, Qiuya Zhang, Yuwen Gong, Mengru Sun, Shenghan Feng, Youzhi Xu, Yiming Liu and Zhe Liu
Inorg. Chem., 2022, 61, 20008
DOI: 10.1021/acs.inorgchem.2c03279

Ruthenium-p-Cymene Complexes Incorporating Substituted Pyridine–Quinoline Ligands with –Br (Br-Qpy) and –Phenoxy (OH-Ph-Qpy) Groups for Cytotoxicity and Catalytic Transfer Hydrogenation Studies: Synthesis and Characterization
Alexandros Dritsopoulos, Nikolaos Zacharopoulos, Aigli-Eleonora Peyret, Eftychia Karampella, Nikolaos Tsoureas, Antigoni Cheilari, Christina Machalia, Evangelia Emmanouilidou, Aikaterini K. Andreopoulou, Joannis K. Kallitsis and Athanassios I. Philippopoulos
Chemistry, 2024, 6, 773
DOI: 10.3390/chemistry6040046

Naphthalimide-Tagged Ruthenium–Arene Anticancer Complexes: Combining Coordination with Intercalation
Kelly J. Kilpin, Catherine M. Clavel, Fabio Edafe and Paul J. Dyson
Organometallics, 2012, 31, 7031
DOI: 10.1021/om3007079

Anticancer activity of multinuclear arene ruthenium complexes coordinated to dendritic polypyridyl scaffolds
Preshendren Govender, Nathan C. Antonels, Johan Mattsson, Anna K. Renfrew, Paul J. Dyson, John R. Moss, Bruno Therrien and Gregory S. Smith
Journal of Organometallic Chemistry, 2009, 694, 3470
DOI: 10.1016/j.jorganchem.2009.06.028

Binuclear dichlorido(η6‐p‐cymene)ruthenium(II) complexes with bis(nicotinate)‐ and bis(isonicotinate)‐polyethylene glycol ester ligands
Thomas Eichhorn, Evamarie Hey‐Hawkins, Danijela Maksimović‐Ivanić, Marija Mojić, Jürgen Schmidt, Sanja Mijatović, Harry Schmidt and Goran N. Kaluđerović
Applied Organom Chemis, 2015, 29, 20
DOI: 10.1002/aoc.3238

Not All Binding Sites Are Equal: Site Determination and Folding State Analysis of Gas‐Phase Protein‐Metallodrug Adducts
Liam Eade, Matthew P. Sullivan, Timothy M. Allison, David C. Goldstone and Christian G. Hartinger
Chemistry A European J, 2024, 30
DOI: 10.1002/chem.202400268

Rollover Cyclometalated Bipyridine Platinum Complexes as Potent Anticancer Agents: Impact of the Ancillary Ligands on the Mode of Action
Maria V. Babak, Martin Pfaffeneder-Kmen, Samuel M. Meier-Menches, Maria S. Legina, Sarah Theiner, Cynthia Licona, Christophe Orvain, Michaela Hejl, Muhammad Hanif, Michael A. Jakupec, Bernhard K. Keppler, Christian Gaiddon and Christian G. Hartinger
Inorg. Chem., 2018, 57, 2851
DOI: 10.1021/acs.inorgchem.7b03210

Square Planar Platinum(II) Complexes with N,S-Donor Ligands: Synthesis, Characterisation, DNA Interaction and Cytotoxic Activity
Mohan N. Patel, Chintan R. Patel, Hardik N. Joshi and Pankaj A. Vekariya
Appl Biochem Biotechnol, 2014, 172, 1846
DOI: 10.1007/s12010-013-0618-z

Catalytic reactions promoted by metal complexes stabilized by 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane (PTA) and derivatives. A brief survey of recent results
Antonella Guerriero and Luca Gonsalvi
Inorganica Chimica Acta, 2024, 572, 122295
DOI: 10.1016/j.ica.2024.122295

Cyclometalated iridium(III) complex of 6‐hydroxydipyrido[3,2‐a:2′,3′‐c]phenazine: synthesis, and acid–base and avid DNA binding properties
Yan‐Min Chen, An‐Guo Zhang and Ke‐Zhi Wang
Applied Organom Chemis, 2011, 25, 521
DOI: 10.1002/aoc.1796

A Comparison of Ruthenium‐Catalysed Arene Hydrogenation Reactions in Water and 1‐Alkyl‐3‐methylimidazolium Tetrafluoroborate Ionic Liquids
Paul J. Dyson, David J. Ellis, William Henderson and Gábor Laurenczy
Adv Synth Catal, 2003, 345, 216
DOI: 10.1002/adsc.200390015

Influence of the Linker Length on the Cytotoxicity of Homobinuclear Ruthenium(II) and Gold(I) Complexes
Lucinda K. Batchelor, Emilia Păunescu, Mylène Soudani, Rosario Scopelliti and Paul J. Dyson
Inorg. Chem., 2017, 56, 9617
DOI: 10.1021/acs.inorgchem.7b01082

Organometallic ruthenium-based antitumor compounds with novel modes of action
Wee Han Ang, Angela Casini, Gianni Sava and Paul J. Dyson
Journal of Organometallic Chemistry, 2011, 696, 989
DOI: 10.1016/j.jorganchem.2010.11.009

Aqueous phase carbon dioxide and bicarbonate hydrogenation catalyzed by cyclopentadienyl ruthenium complexes
Sylvain S. Bosquain, Antoine Dorcier, Paul J. Dyson, Mikael Erlandsson, Luca Gonsalvi, Gábor Laurenczy and Maurizio Peruzzini
Applied Organom Chemis, 2007, 21, 947
DOI: 10.1002/aoc.1317

Cytotoxicity of ruthenium(II) piano-stool complexes with imidazole-based PN ligands
Wilhelm Huber, Philip Bröhler, Wim Wätjen, Walter Frank, Bernhard Spingler and Peter C. Kunz
Journal of Organometallic Chemistry, 2012, 717, 187
DOI: 10.1016/j.jorganchem.2012.06.027

Versatile Applications of Metallopolymers
Stefan Götz, Stefan Zechel, Martin D. Hager, George R. Newkome and Ulrich S. Schubert
Progress in Polymer Science, 2021, 119, 101428
DOI: 10.1016/j.progpolymsci.2021.101428

100 years of metal coordination chemistry: from Alfred Werner to anticancer metallodrugs
Nicolas P. E. Barry and Peter J. Sadler
Pure and Applied Chemistry, 2014, 86, 1897
DOI: 10.1515/pac-2014-0504

Conjugating Biotin to Ruthenium(II) Arene Units via Phosphine Ligand Functionalization
Lorenzo Biancalana, Martyna Gruchała, Lucinda K. Batchelor, Andrzej Błauż, Andrea Monti, Guido Pampaloni, Błażej Rychlik, Paul J. Dyson and Fabio Marchetti
Eur J Inorg Chem, 2020, 2020, 1061
DOI: 10.1002/ejic.201900922

Organometallic Anticancer Compounds
Gilles Gasser, Ingo Ott and Nils Metzler-Nolte
J. Med. Chem., 2011, 54, 3
DOI: 10.1021/jm100020w

A Ru(II) complex with 2-(4-(methylsulfonyl)phenyl)-1H-imidazo[4,5-f][1,10]phenanthroline: Synthesis, characterization, and acid–base and DNA-binding properties
Jie Gao, Zhi-Ping Wang, Cui-Li Yuan, Hai-Shun Jia and Ke-Zhi Wang
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2011, 79, 1815
DOI: 10.1016/j.saa.2011.05.063

Drive to organoruthenium and organoiridium complexes from organoplatinum: Next-generation anticancer metallotherapeutics
Prithvi Moharana, Deblina Ghosh and Priyankar Paira
Inorganic Chemistry Communications, 2021, 124, 108364
DOI: 10.1016/j.inoche.2020.108364

Exploring metallodrug–protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound
Angela Casini, Chiara Gabbiani, Elena Michelucci, Giuseppe Pieraccini, Gloriano Moneti, Paul J. Dyson and Luigi Messori
J Biol Inorg Chem, 2009, 14, 761
DOI: 10.1007/s00775-009-0489-5

Expanding the Range of Pyrenylphosphines and Their Derived Ru(II)-Arene Complexes
Laia Rafols, Sara Torrente, David Aguilà, Vanessa Soto-Cerrato, Ricardo Pérez-Tomás, Patrick Gamez and Arnald Grabulosa
Organometallics, 2020, 39, 2959
DOI: 10.1021/acs.organomet.0c00302

Dual Molecular Light Switches for pH and DNA Based on a Novel Ru(II) Complex. A Non-Intercalating Ru(II) Complex for DNA Molecular Light Switch
An-Guo Zhang, You-Zhuan Zhang, Zhi-Ming Duan, Ke-Zhi Wang, Hui-Bo Wei, Zu-Qiang Bian and Chun-Hui Huang
Inorg. Chem., 2011, 50, 6425
DOI: 10.1021/ic102126m

Stable, Water‐Soluble Pta‐Based Ru–Ag Organometallic Polymers
Chaker Lidrissi, Antonio Romerosa, Mustapha Saoud, Manuel Serrano‐Ruiz, Luca Gonsalvi and Maurizio Peruzzini
Angew Chem Int Ed, 2005, 44, 2568
DOI: 10.1002/anie.200462790

Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms
Jana Hildebrandt, Norman Häfner, Daniel Kritsch, Helmar Görls, Matthias Dürst, Ingo B. Runnebaum and Wolfgang Weigand
IJMS, 2022, 23, 4976
DOI: 10.3390/ijms23094976

Synthesis of Novel N-Heterocyclic Carbene-Ruthenium (II) Complexes, “Precious” Tools with Antibacterial, Anticancer and Antioxidant Properties
Jessica Ceramella, Rubina Troiano, Domenico Iacopetta, Annaluisa Mariconda, Michele Pellegrino, Alessia Catalano, Carmela Saturnino, Stefano Aquaro, Maria Stefania Sinicropi and Pasquale Longo
Antibiotics, 2023, 12, 693
DOI: 10.3390/antibiotics12040693

An overview of advancement of organoruthenium(II) complexes as prospective anticancer agents
Masrat Bashir, Imtiyaz Ahmad Mantoo, Farukh Arjmand, Sartaj Tabassum and Imtiyaz Yousuf
Coordination Chemistry Reviews, 2023, 487, 215169
DOI: 10.1016/j.ccr.2023.215169

PGSE NMR Studies on RAPTA Derivatives: Evidence for the Formation of H-Bonded Dicationic Species
Sandra Bolaño, Gianluca Ciancaleoni, Jorge Bravo, Luca Gonsalvi, Alceo Macchioni and Maurizio Peruzzini
Organometallics, 2008, 27, 1649
DOI: 10.1021/om701131s

Synthesis and Antiproliferative Activity of New Ruthenium Complexes with Ethacrynic-Acid-Modified Pyridine and Triphenylphosphine Ligands
Gabriele Agonigi, Tina Riedel, Stefano Zacchini, Emilia Păunescu, Guido Pampaloni, Niccolò Bartalucci, Paul J. Dyson and Fabio Marchetti
Inorg. Chem., 2015, 54, 6504
DOI: 10.1021/acs.inorgchem.5b00802

Anticancer activity of Ru- and Os(arene) compounds of a maleimide-functionalized bioactive pyridinecarbothioamide ligand
Muhammad Hanif, Sally Moon, Matthew P. Sullivan, Sanam Movassaghi, Mario Kubanik, David C. Goldstone, Tilo Söhnel, Stephen M.F. Jamieson and Christian G. Hartinger
Journal of Inorganic Biochemistry, 2016, 165, 100
DOI: 10.1016/j.jinorgbio.2016.06.025

Pyridine and pyrimidine functionalized half-sandwich Ru(II)-N heterocyclic carbene complexes: Synthesis, structures, spectra, electrochemistry and biological studies
Bidyut K. Rana, Gourisankar Roymahapatra, Himadri Sekhar Das, Santanab Giri, Marlon H. Cardoso, Octávio L. Franco, Kiran K. Nakka, Manas K. Santra, Partha Pratim Bag, Valerio Bertolasi and Joydev Dinda
Journal of Molecular Structure, 2021, 1245, 130939
DOI: 10.1016/j.molstruc.2021.130939

Ruthenium(II)-Arene Complexes of the Water-Soluble Ligand CAP as Catalysts for Homogeneous Transfer Hydrogenations in Aqueous Phase
Antonella Guerriero, Maurizio Peruzzini and Luca Gonsalvi
Catalysts, 2018, 8, 88
DOI: 10.3390/catal8020088